Summary of Pearls and Pitfalls {#FPar1}
==============================

The concept of personalized medicine and the remarkable advances in lung cancer genetics and therapy in the past decade have changed lung pathology practice dramatically.The 2015 World Health Organization (WHO) classification of tumors of the lung specifies that immunohistochemistry is required for lung cancer diagnosis, not only for small biopsies and fine needle aspiration (FNA) specimens but also for certain resected specimens such as solid adenocarcinoma (ADC), nonkeratinizing squamous cell carcinom a, large cell carcinoma, neuroendocrine tumors, and sarcomatoid carcinomas.New criteria and terminology for the diagnosis of lung cancer based on small biopsies and cytology are proposed in the 2015 WHO classification and are summarized in Tables [6.1](#Tab1){ref-type="table"} and [6.2](#Tab2){ref-type="table"}.Table 6.1Terminology and criteria for adenocarcinoma, squamous cell carcinoma, and non-small cell carcin oma, not otherwise specified, in small biopsies and cytology specimens compared with those for resection specimensSmall biopsy/cytology terminologyMorphology/immunohistochemistry2015 WHO classification of resection specimensADC (describe patterns)Morphologic ADC patterns clearly presentADC predominant pattern: lepidic, acinar, papillary, solid, and micropapillaryADC with lepidic pattern (if pure, add note: an invasive component cannot be excluded)Minimally invasive ADC, ADC in situ, or an invasive ADC with a lepidic componentInvasive mucinous ADC (describe patterns; use term mucinous ADC with lepidic pattern if pure)Invasive mucinous ADCADC with colloid featuresColloid ADCADC with fetal featuresFetal ADCADC with enteric featuresEnteric ADCNSCC, favor ADCMorphologic ADC patterns not present but supported by special stains (i.e., TTF1+)ADC (solid pattern may be just one component of the tumor)SqCCMorphologic squamous cell pattern clearly presentSqCCNSCC, favor SqCCMorphologic squamous cell patterns not present but supported by stain (i.e., p40+)SqCC (solid pattern may be just one component of the tumor)NSCC NOSNo clear ADC, squamous or neuroendocrine morphology or staining patternLarge cell carcinomaAdapted with permission of Elsevier from Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JH, Beasley MB, et al.; WHO Panel. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10(9):1243--60*ADC* adenocarcinoma, *TTF1* thyroid transcription factor 1, *SqCC* squamous cell carcinoma, *NSCC* non- small cell carcinoma, *NOS* not otherwise specified, *WHO* World Health Organization Table 6.2Diagnostic terminology for small biopsy/cytology compared with that of the 2015 World Health Organization (WHO) in resection specimens with small cell carcin oma, LCNEC, adenosquamous carcino ma, and sarcomatoid carcino maSmall biopsy/cytology terminology/criteria2015 WHO classification of resectionsSmall cell carcinomaSmall cell carcinomaNSCC with NE morphology and positive NE markers, possible LCNECLCNECNSCC with NE morphology. If negative NE markers comment: This is an NSCC where LCNEC is suspected, but stains fails to demonstrate NE differentiationLCNEMMorphologic squamous cell and ADC patterns present: NSCC, NOS. Comment that ADC and squamous components are present, and this could represent adenosquamous carcinomaAdenosquamous carcinoma (if both components ≥10%)No morphologic squamous cell or ADC patterns, but immunostains favor separate squamous and ADC components: NSCC, NOS. Specify the IHC results and the interpretation. Comment that this could represent adenosquamous carcinomaADC, SqCC, adenosquamous carcinoma, or large cell carcinoma with unclear IHC featuresNSCC with spindle cell and/or giant cell carcinoma (mention if ADC or SqCC is present)Pleomorphic, spindle cell, and/or giant cell carcinomaAdapted with permission of Elsevier from Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JH, Beasley MB, et al.; WHO Panel. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10(9):1243--60*WHO* World Health Organization, *LCNEC* large cell neuroendocrine carcinoma, *NSCC* non- small cell carcinoma, *NE* neuroendocrine, *LCNEM* large cell carcinoma with neuroendocrine morphology, *ADC* adenocarcinoma, *NOS* not otherwise specified, *SqCC* squamous cell carcinoma, *IHC* immunohistochemistryThe role of cytopathologists has expanded to not only making a specific diagnosis, including histopathological subtyping of tumors, but also to thoughtfully utilizing the limited material for necessary genetic studies to help personalize treatment strategies for advanced lung cancer patients.Thyroid transcription factor 1 ( TTF1) and napsin A are accepted markers for ADC differentiation; p40 is reported to be the most specific and sensitive marker for squamous cell differentiation. A reasonable recommendation is that, when immunohistochemistry is deemed necessary, at least one antibody each for squamous and glandular differentiation, but no more than two antibodies, should be used for an initial workup (e.g., TTF1 and p40 or p63). Thus a limited panel of TTF1 and p40 (or p63) is suggested for subtyping the tumor to preserve tissue for molecular testing.Molecular testing for epithelial growth factor receptor (*EGFR*) mutation and anaplastic lymphoma kinase (*ALK*) rearrangement is recommended in tumors classified as ADC and in cases where an ADC component cannot be excluded.When evaluating a computed tomography (CT)-guided FNA of a lung lesion in the periphery, mesothelial cells are frequently seen on smears; reactive mesothelial cells may mimic carcinoma, and caution should be taken.Diagnosis of ADC with a lepidic growth pattern can be challenging in FNA specimens. Both quality (degree of atypia) and quantity (groups of atypical cells) need to be considered. In a typical case of ADC with a lepidic growth pattern, the smears tend to be very cellular, containing many groups of atypical epithelial cells. In contrast, in a reactive condition, such as pulmonary infarction, atypical reactive pneumocytes are usually less numerous.In mucinous ADC with a lepidic growth pattern, the neoplastic epithelial cells may mimic pulmonary macrophages. Features such as a mucinous background, cytoplasmic mucin/vacuoles, eccentrically located nuclei, and more abundant cytoplasm are helpful in reaching a correct diagnosis.Basaloid squamous cell carcinoma may mimic small cell carcinoma; therefore, cellblock preparation in conjunction with immunostains will be helpful.Infection such as aspergillosis may result in squamous cells with significant cytological atypia; therefore, infectious etiologies should be excluded before a diagnosis of well-differentiated squamous cell carcinoma is rendered.A lesion from the mediastinum should be considered if cytological features do not fit the description of a typical "lung lesion."Thymoma is rare in young patients and children. In lymphocyte-dominant thymoma, the main component of the aspirate may contain cortical thymocytes with expression of terminal deoxynucleotidyl transferase ( TdT) and cluster of differentiation (CD)99; therefore, caution should be taken to avoid misdiagnosing it as a lymphoblastic lymphoma.Thymic neuroendocrine neoplasm may mimic an epithelial-dominant thymoma; therefore, immunohistochemistry should be performed in cases with equivocal features.

Lung {#Sec1}
====

Tables [6.1](#Tab1){ref-type="table"} and [6.2](#Tab2){ref-type="table"} summarize new criteria and terminology for the diagnosis of lung cancer based on small biopsies and cytology from the 2015 WHO classification.

Normal Cytology {#Sec2}
---------------

### Upper Respiratory Tract {#Sec3}

Ciliated columnar cells , see Fig. [6.1](#Fig1){ref-type="fig"}.Fig. 6.1Normal ciliated respiratory columnar cells , Diff-Quik stainSquamous cells , see Fig. [6.2](#Fig2){ref-type="fig"}.Fig. 6.2Normal squamous cells, Pap stain

### Lower Respiratory Tract {#Sec4}

Trachea and bronchiCiliated columnar cellsGoblet cells , see Fig. [6.3](#Fig3){ref-type="fig"}.Fig. 6.3Benign goblet cells, Pap stainBasal/reserve cells , see Fig. [6.4](#Fig4){ref-type="fig"}.Fig. 6.4Normal reserve cells, Pap stainTerminal bronchiolesNon-ciliated cuboidal/columnar cells (Clara cells)AlveoliType I and II pneumocytesAlveolar macrophages , see Fig. [6.5](#Fig5){ref-type="fig"}.Fig. 6.5Pulmonary macrophages, Pap stain

Respiratory Infections {#Sec5}
----------------------

### Viral Infections {#Sec6}

Specific viral infections, such as herpes simplex (Fig. [6.6](#Fig6){ref-type="fig"}) and cytomegalovirus (Fig. [6.7](#Fig7){ref-type="fig"}), can cause significant cytological changes that may mimic a malignant process. The diagnosis can be confirmed by immunoperoxidase studies. Fig. 6.6Herpes simplex viral inclusions, H&E Fig. 6.7Cytomegaloviral inclusion , Pap stain

Severe acute respiratory syndrome ( SARS) caused by a novel coronavirus ( SARS-CoV) became a worldwide outbreak in 2003, affecting more than 8000 patients, with a fatality rate of 9.2%. SARS-CoV belongs to a family of large, positive, single-stranded ribonucleic acid (RNA) viruses. The key pathologic finding is diffuse alveolar damage ( DAD) . Depending on different phases in the disease progression, the composition of inflammatory cells may vary; however, macrophages (including multinucleated forms) and lymphocytes usually predominate. Other pathologic findings, such as fibrosis, prominent vascular injury, hemophagocytosis, squamous metaplasia, apoptosis, and atypical pneumocytes, including multinucleated giant pneumocytes with irregularly distributed nuclei or pneumocytes with large atypical nuclei, prominent eosinophilic nucleoli, and granular amphophilic cytoplasm, were reported. Ancillary tests, such as in situ hybridization, immunohistochemistry, viral isolation, or reverse transcription polymerase chain reaction (RT-PCR), are necessary to confirm the diagnosis. Representative images are shown in Fig. [6.8](#Fig8){ref-type="fig"}a, b. Fig. 6.8Alveolar lavage from a patient with severe acute respiratory syndrome, with confirmed coronavirus infection. (**a**) Atypical pneumocytes with large nuclei, prominent eosinophilic nucleoli, and granular amphophilic cytoplasm in a background of marked acute inflammation, Pap stain; (**b**) typical metaplastic squamous cells with enlarged nuclei, hyperchromatic, smudged chromatin, Pap stain

### Fungal Infections {#Sec7}

FNA is a useful means of diagnosing pulmonary fungal infection, which should be suspected whenever there is granulomatous inflammation. Silver or periodic acid-Schiff (PAS) stains are used on cellblock sections.

The common fungal infections include (1) *Candida* species ; (2) *Aspergillus* species , Fig. [6.9](#Fig9){ref-type="fig"}; (3) phycomycosis (such as mucormycosis); (4) *Cryptococcus neoformans*, Fig. [6.10](#Fig10){ref-type="fig"}a--d; (5) *Histoplasma capsulatum*, Fig. [6.11](#Fig11){ref-type="fig"}a, b; (6) *Blastomyces dermatitidis*, Fig. [6.12](#Fig12){ref-type="fig"}a, b; (7) *Coccidioides immitis*, Fig. [6.13](#Fig13){ref-type="fig"}a, b; and (8) *Pneumocystis carinii*, Fig. [6.14](#Fig14){ref-type="fig"}a--c. The morphological features of these fungi are summarized in Table [6.3](#Tab3){ref-type="table"}. Table 6.3Morphological features of fungi commonly seen in pulmonary cytological samplesFungiFormsHyphal branchesAverage diameter (um)Budding pattern*Candida spp.*Budding yeastPseudohyphaeNot applicable4Constricted neck*Aspergillus spp.*Hyphae with 45-degree angle45 degree5--10Not applicable*Mucormycosis*Hyphae with acute angle90 degree10--15Not applicable*Histoplasma capsulatum*Budding yeastNot applicable2--4Constricted neck*Cryptococcus neoformans*YeastNot applicable5--8Constricted neck*Blastomyces dermatitidis*YeastNot applicable8--15Broad-based*Coccidioides immitis*Endospores SpherulesNot applicableEndospores 2--5Spherules −100Not applicable~*a*~ *Pneumocystis carinii*Helmet-shaped cystsNot applicable6--8Not applicable^a^Genetic data suggest *Pneumocystis carinii* is more closely related to fungi*spp* species (many) Fig. 6.9*Aspergillus* species , alveolar lavage, Pap stain. The fungal hyphae exhibit septation, with dichotomous 45 degree angle branching. There are pulmonary macrophages and neutrophil-predominant mixed inflammatory cells in the background Fig. 6.10*Cryptococcus neoformans*, bronchial brushing and alveolar lavage. (**a**) Round/oval, variable size yeast forms in background of respiratory epithelial cells, bronchial brushing, Pap stain; (**b**) alveolar lavage, showing slightly variable size, round/oval yeast forms with thick capsule and narrow-necked budding, H&E; (**c**) alveolar lavage, cellblock, H&E, showing round to oval yeast form; (**d**) alveolar lavage, the thick mucinous capsule showing bright red stain with mucicarmine, cellblock Fig. 6.11*Histoplasma capsulatum*, lung lesion, fine needle aspiration. (**a**) Small, budding, intracellular yeast forms, 2--5 microns, Diff-Quick; (**b**) cellblock, Grocott's methenamine silver (GMS) stain, showing small yeast forms Fig. 6.12*Blastomyces dermatitidis*, lung lesion, sputum. (**a**) Budding yeast form, broad base, cellblock, H&E; (**b**) sputum, broad-based budding yeast form, Pap stain Fig. 6.13*Coccidioides immitis*. (**a**) Cellblock, spherule form containing endospores, H&E; (**b**) spherule form containing endospores, Pap stain Fig. 6.14*Pneumocystis carinii*, alveolar lavage. (**a**) Foamy proteinaceous spheres, Pap stain; (**b**) foamy proteinaceous spheres, cellblock, H&E; (**c**) GMS stain reveals small oval or cup-shaped yeast forms, cellblock

### Strongyloidiasis {#Sec8}

Pulmonary strongyloidiasis affects immunocompetent and, more commonly, immunosuppressed persons presenting with pneumonitis with hemoptysis. The etiological agent is the nematode. *Strongyloides stercoralis* in sputum is shown in Fig. [6.15](#Fig15){ref-type="fig"}. Fig. 6.15Strongyloides stercoralis, sputum, Pap stain

### Bacterial Infection {#Sec9}

Infection by *Mycobacterium tuberculosis* is often a granulomatous inflammation containing clusters of epithelioid histiocytes, lymphocytes, and Langhans giant cells, with or without necrosis. In immunocompromised patients there may be abundant acid-fast organisms without obvious granulomatous inflammation.

Acquired immunodeficiency syndrome (AIDS) patients are especially susceptible to *Mycobacterium avium-intracellulare*, an acid-fast organism producing negative images on Romanowsky stain. Special stains on cellblock section are particularly helpful.

*Nocardia*, a weakly acid-fast filamentous organism, often infects immunocompromised patients, producing cavitary nodules on radiographs, which may mimic a neoplastic process .

### Other Types of Granulomatous Inflammation {#Sec10}

#### Sarcoidosis {#Sec11}

##### Key Clinical Features {#FPar2}

Sarcoidosis is characterized by non-caseating granulomas in many organs, most commonly the lung.

##### Key Radiological Features {#FPar3}

Chest x-ray: bilateral hilar adenopathy is a classic finding; variable lung parenchyma changes, from normal, diffuse reticular, or ground glass opacities, nodular consolidation or cystic scarring.CT and positron emission tomography (PET) scan can also be used.

##### Cytological Features {#FPar4}

Aggregates of epithelioid histiocytes, with or without Schaumann and asteroid bodiesMultinucleated giant cells and lymphocytes

##### Differential Diagnosis {#FPar5}

An essential part of the diagnosis of sarcoidosis is the exclusion of alternative possibilities:Granulomas caused by infectious agents, such as mycobacterial infection and fungal infectionDrug-induced, hypersensitivity pneumonitis, or foreign body granulomatosisPulmonary histiocytic disordersGranulomatous disorders associated with vascular inflammation such as Wegener granulomatosis and Churg-Strauss syndrome

#### Wegener Granulomatosis {#Sec12}

##### Key Clinical Features {#FPar6}

Wegener granulomatosis is characterized by necrotizing vasculitis and may present as a lung mass with or without involvement of nasal passages and kidneys.

##### Key Radiological Features {#FPar7}

Multiple pulmonary nodules on imaging

##### Cytological Features {#FPar8}

Neutrophils, giant cells, necrotic collagen, and epithelioid histiocytesThe findings are nonspecific; therefore, serologic studies are necessary.

##### Differential Diagnosis {#FPar9}

Granulomatous inflammationsMetastatic diseasesNon-Hodgkin lymphomas

#### Nodular Pulmonary Amyloidosis (Amyloid Tumor) {#Sec13}

##### Key Clinical Features {#FPar10}

Amyloid deposits in the lung, forming discrete nodular masses

##### Key Radiological Features {#FPar11}

Discrete pulmonary nodules/masses (amyloidomas) on imaging

##### Cytological Features {#FPar12}

Irregular, waxy, amorphous, hypocellular material with a scalloped, occasionally cracked appearance, which is blue-green on Papanicolaou (Pap) stain and shows apple-green dichroism under polarized light after staining with Congo red

##### Differential Diagnosis {#FPar13}

Granulomatous inflammationsMetastatic diseasesNon-Hodgkin lymphomas

Pulmonary Neoplasms {#Sec14}
-------------------

The 2015 *WHO Classification* *of Tumors of the Lung, Pleura, Thymus and Heart* has been published recently. There are numerous important changes in the classification of lung tumors, as summarized in Table [6.4](#Tab4){ref-type="table"}.Table 6.42015 World Health Organization (WHO) classification of lung tumors*Epithelial tumors*Adenocarcinoma  Lepidic adenocarcinoma  Acinar adenocarcinoma  Papillary adenocarcinoma  Micropapillary adenocarcinoma  Solid adenocarcinoma Invasive mucinous adenocarcinomaMixed invasive mucinous and nonmucinous adenocarcinoma  Colloid adenocarcinoma  Fetal adenocarcinoma  Enteric adenocarcinoma  Minimally invasive adenocarcinoma   Nonmucinous   Mucinous  Preinvasive lesions   Atypical adenomatous hyperplasia  Adenocarcinoma in situ   Nonmucinous   MucinousSquamous cell carcinoma Keratinizing squamous cell carcinoma  Nonkeratinizing squamous cell carcinoma  Basaloid squamous cell carcinoma  Preinvasive lesion   Squamous cell carcinoma  in situNeuroendocrine tumors  Small cell carcinoma   Combined small cell  carcinoma  Large cell neuroendocrine carcinoma   Combined large cell neuroendocrine carcinoma  Carcinoid tumors   Typical carcinoid tumor   Atypical carcinoid tumorNeuroendocrine tumors (continued)Preinvasive lesion  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasiaLarge cell carcinomaAdenosquamous carcinomaSarcomatoid carcinomas  Pleomorphic carcinoma  Spindle cell carcinoma  Giant cell carcinoma  Carcinosarcoma  Pulmonary blastomaOther and Unclassified carcinomas  Lymphoepithelioma-like carcinoma Nuclear protein in testis (NUT) carcinomaSalivary gland-like tumors  Mucoepidermoid carcinoma  Adenoid cystic carcinoma  Epithelial-myoepithelial carcinoma  Pleomorphic adenomaPapillomas  Squamous cell papilloma  Exophitic  Inverted  Glandular papilloma  Mixed squamous and glandular papillomaAdenomas  Sclerosing pneumocytoma  Alveolar adenoma  Papillary adenoma  Mucinous cystadenoma  Mucous gland adenoma*Mesenchymal tumors*Pulmonary hamartomaChondromaPEComatous tumors  Lymphangioleiomyomatosis PEComa, benign   Clear cell tumor PEComa, malignantCongenital peribronchial myofibroblastic tumorDiffuse pulmonary lymphangiomatosisInflammatory myofibroblastic tumorEpithelioid hemangioendotheliomaPleuropulmonary blastomaSynovial sarcomaPulmonary artery intimal sarcomaPulmonary myxoid sarcoma with *EWSR1-CREB1* translocationMyoepithelial tumors  Myoepithelioma Myoepithelial carcinoma*Lymphohistiocytic tumors*Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)Diffuse large cell lymphomaLymphomatoid granulomatosisIntravascular large B-cell lymphomaPulmonary Langerhans cell histiocytosisErdheim-Chester disease*Tumors of ectopic origin*Germ cell tumors Teratoma, mature Teratoma, immatureIntrapulmonary thymomaMelanomaMeningioma, not otherwise specified (NOS)*Metastatic tumors*Used with permission from Travis WD, Brambilla E, Burke AP, Marx A, Nicholson A. WHO classification of tumours of the lung, pleura, thymus and heart. Lyon, France: IARC; 2015

### Representative Benign Neoplasms of the Lung {#Sec15}

#### Pulmonary Hamartoma {#Sec16}

##### Key Clinical Features {#FPar14}

The most common benign pulmonary neoplasmUsually asymptomatic, incidental findingCommon in males, especially elderly men

##### Key Radiological Features {#FPar15}

Chest x-ray: solitary or multiple discrete, round, golf ball-like lesions ("coin lesions"), usually peripherally located, about 10% endobronchial

##### Cytological Features {#FPar16}

A mixture of mesenchymal and epithelial elementsImmature fibromyxoid matrixMature cartilage with chondrocytes in lacunaeBenign glandular cellsAdipocytesRepresentative images are shown in Fig. [6.16](#Fig16){ref-type="fig"}a, b.Fig. 6.16Pulmonary hamartoma. (**a**) Sparsely cellular chondromyxoid matrix material containing scattered, benign, spindled, and stellate mesenchymal cells, Pap stain; (**b**) clusters of epithelial cells embedded in stromal, Pap stain; (**c**, **d**) histopathology, well-circumscribed, lobulated nodules of mesenchymal tissue including chondroid or chondromyxoid tissue, fat, and connective tissue intermixed with clefts of respiratory epithelial cells, H&E

##### Differential Diagnosis {#FPar17}

Epithelial malignancy

##### Histology {#FPar18}

Round to multilobulated, well-circumscribed tumor nodules composed of mesenchymal tissues, including chondroid or chondromyxoid tissue, fat, connective tissue, smooth muscle, and bone in various proportions, intermixed with clefts of respiratory epithelial cellsChondromyxoid tissue usually predominates.Representative images are shown in Fig. [6.16](#Fig16){ref-type="fig"}c, d.

**Immunohistochemistry** Immunohistochemistry is usually not necessary for diagnosis.Pulmonary hamartomas have a high frequency of translocation t(3;12)(q27--28;q14--15) leading to a gene fusion of the high mobility group protein gene AT-hook 2 (*HMGA2)* and the lipoma preferred partner (*LPP)* gene.

#### Inflammatory Myofibroblastic Tumor {#Sec17}

##### Key Clinical Features {#FPar19}

Most often young patients, under the age of 40Male = femaleThe most common endobronchial mesenchymal lesion in childhood

##### Key Radiological Features {#FPar20}

Chest x-ray: a peripheral, discrete, solitary nodule. If endobronchial location, post-obstructive pneumonia and atelectasis may be evident.

##### Cytological Features {#FPar21}

Spindle cellsStoriform patternPolymorphous inflammatory cellsMinimal to no necrosis

##### Differential Diagnosis {#FPar22}

SarcomaMesotheliomaSolitary fibrous tumor

##### Histology {#FPar23}

Composed of a mixture of spindle cells and obscuring inflammatory cell infiltrates, including lymphocytes, plasma cells, and histiocytes.Touton giant cells are often seen.The spindle cells contain oval nuclei with a fine chromatin pattern, inconspicuous nucleoli, and abundant bipolar lightly eosinophilic cytoplasm arranged in fascicles or a storiform architecture.Representative images are illustrated in Fig. [6.17](#Fig17){ref-type="fig"}a, b.Fig. 6.17Inflammatory myofibroblastic tumor. (**a**, **b**) Histopathology, a mixture of spindle cells and obscuring inflammatory cell infiltrates including lymphocytes, plasma cells, and histiocytes, H&E; (**c**) positive for SMA, IHC; (**d**) negative for S100, IHC

**Immunohistochemistry** Positive for vimentin, smooth muscle actin (SMA), and rarely to desminNegative for myogenin, myoglobin, CD117, and S100 proteinFocal cytokeratin (CK) positivity was reported in 1/3 of cases, likely due to alveolar entrapment.Anaplastic lymphoma kinase 1 (ALK1) expression was noted in 40% of cases.p53 is negative; however, positivity is associated with recurrence and malignant transformation.Representative images are illustrated in Fig. [6.17](#Fig17){ref-type="fig"}c, d.

### Representative Malignant Neoplasms of the Lung {#Sec18}

#### Squamous Cell Carcinoma {#Sec19}

Squamous cell carcinomas are malignant tumors that either morphologically show squamous cell differentiation (keratinization and/or intercellular bridges) or are morphologically undifferentiated non-small cell carcinomas but show squamous cell differentiation immunohistochemically. The 2015 WHO classifications of tumors of the lung reclassified squamous cell carcinomas into keratinizing, nonkeratinizing, and basaloid subtypes. The nonkeratinizing tumors require immunohistochemical proof of squamous differentiation.

##### Key Clinical Features {#FPar24}

About 20% of all pulmonary malignanciesClinical presentation is similar to other non-small cell carcinomas.

##### Key Radiological Features {#FPar25}

Usually a central mass with cavitation and post-obstructive pneumonia

##### Cytological Features {#FPar26}

Keratinizing squamous cell carcinoma:Abundant dyshesive cells with dense cytoplasm, may be orangeophilicPolygonal, rounded, or elongated cellsTadpole or fiber-like cellsPleomorphic, pyknotic nuclei with obscured nucleoli and chromatin detailAnucleated cells and twisted keratin strands (Herxheimer spirals)Representative images are shown in Fig. [6.18](#Fig18){ref-type="fig"}a--d.Fig. 6.18Keratinizing squamous cell carcinoma, cytology. (**a**) Polygonal to round cells with hyperchromatic nuclei and hard cytoplasm, Diff-Quik; (**b**, **c**) polygonal or tadpole cells with pyknotic nuclei and dense, orangeophilic cytoplasm, Pap stain; (**d**) keratin pearls and debris, cell block, H&E

Nonkeratinizing or basaloid squamous cell carcinoma:Cohesive groups of cells with larger nuclei and coarsely granular chromatinCyanophilic cytoplasm on Pap stainRare or no keratinizationRepresentative images are shown in Fig. [6.19](#Fig19){ref-type="fig"}a--f.Fig. 6.19Nonkeratinizing, basaloid squamous cell carcinoma , cytology. (**a**) Cohesive groups of atypical cells with hyperchromatic nuclei and coarse, granular chromatin texture, basaloid, Diff-Quik; (**b**) similar, basaloid, Pap stain; (**c**) cohesive cluster of atypical epithelial cells, no keratinization identified, Diff-Quik; (**d**) similar to C, Pap stain; (**e**) tumor cell cluster in cellblock, H&E; F. p40-decorated tumor nuclei, IHC

##### Differential Diagnosis {#FPar27}

Squamous metaplasiaCavitary infectionPemphigus vulgarisRadiation/chemotherapy effectOther non-small cell carcinomaSmall cell carcinomaUpper airway cancer contamination

##### Histology {#FPar28}

Three subtypes of squamous cell carcinoma in the 2015 WHO classification of tumors of the lung: keratinizing, nonkeratinizing, and basaloid subtypes:Keratinizing squamous cell carcinomas exhibit recognizable keratinization, keratin pearls, and/or intercellular bridges, as illustrated in Fig. [6.20](#Fig20){ref-type="fig"}a, b.Fig. 6.20Squamous cell carcinoma, histopathology. (**a**, **b**) Keratinizing squamous cell carcinoma , H&E; (**c**) nonkeratinizing squamous cell carcinom a, H&E; (**d**) basaloid squamous cell carcinom a exhibits solid islands of larger, hyperchromatic tumor cells with peripheral palisading, H&ENonkeratinizing squamous cell carcinomas are without recognizable keratinization, keratin pearls, or intercellular bridges, as illustrated in Fig. [6.20c](#Fig20){ref-type="fig"}.Basaloid squamous cell carcinomas are tumors with a basaloid component in greater than 50% of the tumor, regardless of the presence of any keratinization, as illustrated in Fig. [6.20d](#Fig20){ref-type="fig"}.

**Immunohistochemistry** Immunohistochemistry is required for the diagnosis of nonkeratinizing squamous cell carcinomas.Squamous cell carcinomas express p40, p63, and CK5/6.TTF1 is usually negative in keratinizing squamous cell carcinomas, may be weakly focally positive in nonkeratinizing squamous cell carcinomas.Representative images are illustrated in Fig. [6.21](#Fig21){ref-type="fig"}a--d.Fig. 6.21Immunophenotype of squamous cell carcinoma. (**a**) Positive nuclear staining for p40, IHC; (**b**) positive CK5/6 staining, IHC; (**c**) negative TTF1 staining, IHC; (**d**) negative CK7 staining, IHCSquamous cell carcinomas of lung are characterized by complex genomic alterations, frequently involving the following pathways:Cyclin-dependent kinase inhibitor 2A/retinoblastoma 1/nuclear factor, erythroid 2 like 2/Kelch-like ECH-associated protein 1/cullin 3 (CDKN2A/RB1, NFE2L2/KEAP1/CUL3)Phosphoinositide 3-kinase/protein kinase B (PI3K/AKT)Sex-determining region Y box 2/tumor protein 63/Notch (Drosophila) homolog 1(*SOX2/TP63/NOTCH1)*

Gene copy number alterations involving chromosomes 3q (*SOX2, TP63*), 7p (*EGFR*), and 8p (fibroblast growth factor receptor 1 \[*FGFR1\]*) are characteristic. Almost all tumors display somatic mutation of tumor protein 53 (*TP53)*. Deletion of chromosome 9p (*CDKN2A*) was observed in 72% of cases .

#### Adenocarcinoma ( ADC) {#Sec20}

##### Key Clinical Features {#FPar29}

The most common primary pulmonary malignancy, accounting for about 40% of cases.Mortality and incidence rates have generally been highest in high-income countries but are now declining, especially in younger males and females.Has been more common in men than in women, but has begun to converge.

##### Key Radiological Features {#FPar30}

Usually a solitary peripheral nodule/mass

##### Cytological Features {#FPar31}

Cohesive, three-dimensional groups.Eccentric, irregular nuclei with granular chromatin, and prominent nucleoli.Transparent, foamy cytoplasm, may have secretory vacuoles.Invasive mucinous ADC: high cellularity, sheets and three-dimensional groups of relatively uniform cells, nuclear enlargement and irregular contour, and nucleoli. May have pseudoinclusions, psammoma bodies, and nuclear grooves/clearing.Poorly differentiated ADC: cohesive groups of overtly malignant cells with nuclear pleomorphism, nuclear membrane irregularity, and coarse chromatin pattern; cytoplasmic mucin is inconspicuous.Representative images are shown in Fig. [6.22](#Fig22){ref-type="fig"}a--h.Fig. 6.22Adenocarcinoma , cytology. (**a**) Cohesive groups of tumor cells with nuclear pleomorphism, nucleoli, and abundant foamy cytoplasm, forming acinar or ductal structure, Diff-Quik; (**b**) the same, Pap stain; (**c**, **d**) invasive mucinous adenocarcinom a, basally located nuclei with no atypia, Pap stain; (**e**) mucinou s tumor cells mimic macrophages in background of mucin, Diff-Quik; Pap stain; (**f**) mucinou s tumor cells mimic macrophages in background of mucin, Pap stain; (**g**) poorly differentiated adenocarcinoma showing pleomorphic tumor cells with no mucinous features identified, Diff-Quik; (**h**) poorly differentiated adenocarcinoma, Pap stain

##### Differential Diagnosis {#FPar32}

Metastatic ADCReactive/reparative changesGoblet cell hyperplasiaGranulomatous inflammationVegetable cells

##### Histology {#FPar33}

In 2011, the new International Association for the Study of Lung Cancer (IASLC)/ American Thoracic Society (ATS)/ European Respiratory Society (ERS) classification of lung ADC proposed significant changes to the 2004 WHO classification for resected tumors:Discontinuing the terms bronchioloalveolar carcinoma (BAC) and mixed subtype ADCAdding adenocarcinoma in situ (AIS) as a preinvasive lesion to join atypical adenomatous hyperplasiaAdding minimally invasive adenocarcinoma (MIA)Classifying invasive ADCs according to the predominant subtype after comprehensive histologic subtyping in 5% incrementsUsing of "lepidic" to describe a noninvasive component (previously BAC) as part of an invasive ADCReplacing mucinous BAC with invasive mucinous ADC excluding tumors that meet the criteria for AIS or MIADiscontinuing the subtypes of clear cell and signet ring ADCDiscontinuing the term mucinous cystadenocarcinoma and including these under the category of colloid ADCIn the 2015 WHO classification, large cell carcinomas with expression of TTF1 and/or napsin A are reclassified as solid ADCs even if mucin is absent. The solid ADC must be distinguished from squamous cell carcinomas and large cell carcinomas by the identification of at least two high-power fields with five or more cells showing intracytoplasmic mucin and/or the expression of TTF1 and/or napsin A.The diagnostic criteria for AIS:Solitary, small tumor ≤3 cm.Purely lepidic growth pattern.No invasion: stromal, vascular, or pleural.No pattern of invasive ADC: acinar, papillary, micropapillary, solid, colloid, enteric, fetal, or invasive mucinous ADC.No spread through air spaces.Mainly nonmucinous cell type, rare mucinous.No or inconspicuous nuclear atypia.Septal widening with sclerosis/elastosis is common .The diagnostic criteria for MIA: Solitary, small tumor ≤3 cm.Predominantly lepidic growth pattern.≤0.5 cm invasive component in greatest dimension in any one focus.The invasive component to be measured includes any histologic subtype other than a lepidic pattern; tumor cells infiltrating myofibroblastic stroma.MIA diagnosis is excluded if the tumor invades lymphatics, blood vessels, air spaces, or pleura, contains tumor necrosis, and spreads through air spaces.The cell type is mostly nonmucinous, but rarely may be mucinous .The 2015 WHO classification of tumors of lung classifies ADC as lepidic, acinar, papillary, micropapillary, or solid according to the predominant pattern after a comprehensive histologic subtyping to identify all of the different histologic patterns in 5% increments.Other variants of ADCs include invasive mucinous ADC, colloid ADC, fetal ADC, and enteric ADC.Representative images are shown in Fig. [6.23](#Fig23){ref-type="fig"}a--d.Fig. 6.23Adenocarcinoma, histopathology and immunophenotype . (**a**) Lepidic growth pattern, H&E; (**b**) micropapillary pattern, H&E; (**c**) mucinou s, H&E; (**d**) fetal adenocarcinom a, H&E; (**e**) nuclear staining for TTF1, IHC; (**f**) positive for CK7, IHC; (**g**) positive for napsin-A, IHC; (**h**) negative for p40, IHC

**Immunohistochemistry** Positive for TTF1 and napsin A: commonly used markers for pneumocytes, with comparable sensitivity, about 75%; much lower TTF1 expression in solid ADCs and mucinous ADCsPositive for CK7Negative for squamous cell markers; however, p63 positivity was reported in up to 30% of lung ADCs.Representative images are shown in Fig. [6.23](#Fig23){ref-type="fig"}e--h.EGFR, Kirsten rat sarcoma viral oncogene (KRAS), and ALK mutations are specific for lung ADCs. The ADCs with *EGFR* or *ALK* alteration are usually located in the periphery; in contrast, the ADCs with *KRAS* mutation are frequently located in hilar region. The prevalence for *KRAS* and *EGFR* mutations is 10--30%; the transforming fusion gene echinoderm microtubule-associated protein-like 4 (*EML4)-ALK* is found in 5% of lung ADCs. The characteristics of patients with *EGFR* mutation are Asians, never smokers, with nonmucinous tumors; for *ALK* mutation, patients are younger age, male gender, and never or light smokers; for *KRAS* mutation patients are non-Asians, smokers, with invasive mucinous ADCs usually negative for TTF1, and positive for mucin (MUC) 2,5,6 immunophenotypes .

#### Neuroendocrine Tumors {#Sec21}

This group of tumor represents a morphologic and biologic spectrum of tumors that is classified by the 2015 WHO classification of tumors of the lung into four types: preinvasive lesion (including diffuse idiopathic pulmonary neuroendocrine cell hyperplasia), carcinoid tumors (including typical and atypical carcinoid tumors), large cell neuroendocrine carcinoma (LCNEC) , including combined LCNEC, and small cell carcinoma (including combined small cell carcinoma).

##### Carcinoid Tumor {#Sec22}

Carcinoid tumors are neuroendocrine epithelial malignancies, including typical carcinoids, defined as those with \<2 mitoses/per 2 mm^2^, lacking necrosis, ≥0.5 cm in size, and atypical carcinoids, which are those with 2--10 mitoses/per 2 mm^2^ and/or foci of necrosis.

###### Key Clinical Features {#FPar34}

Account for \<1% of all lung cancers.Majority (70--90%) are typical carcinoids.More common in female, white, and \<60 years old.Clinical syndromes are uncommon, including carcinoid syndrome, Cushing syndrome, and acromegaly.

###### Key Radiographic Findings {#FPar35}

Chest x-ray: usually a centrally located, lobulated mass with a prominent endobronchial component; one third of tumors in periphery.CT using intravenous contrast medium shows considerable enhancement; calcification, especially in centrally located tumors; atelectasis; bronchiectasis; and hyperlucency for tumors with bronchial involvement.

###### Cytological Features {#FPar36}

Loosely cohesive groups and single uniform cells with granular nuclei and ample eosinophilic cytoplasm and naked nuclei.Round, columnar, or plasmacytoid cells, forming acinar or rosette-like structures.Branching capillaries.Clean background.May show pleomorphism and prominent nucleoli in atypical carcinoids.Mitoses uncommon, no necrosis in typical carcinoids; necrosis and mitosis seen in atypical carcinoids.Representative images are shown in Fig. [6.24](#Fig24){ref-type="fig"}a, b.Fig. 6.24Carcinoid tumors, cytology . (**a**) Loosely cohesive groups and single uniform round to oval cells with granular nuclei and ample eosinophilic cytoplasm, Diff-Quik stain; (**b**) same, Pap stain; (**c**, **d**) typical carcinoid, composed of uniform polygonal and spindled cells arranged in organoid and trabecular patterns, H&E; (**e**, **f**) atypical carcinoid, the cells are more atypical with focal prominent nucleoli, rare necrosis, and 2--10 mitoses/per 2 mm^2^

###### Differential Diagnosis {#FPar37}

Small cell carcinomaLymphomaBenign bronchial epithelial cellsMesenchymal tumor (spindle cell carcinoid)ADC

###### Histology {#FPar38}

Usually uniform polygonal or spindled cells arranged in organoid or trabecular patterns.Other growth patterns also seen: rosette formation, papillary, pseudoglandular, or follicular patterns.Significant pleomorphism and prominent nucleoli may be seen in typical carcinoids.The differential features for atypical carcinoids are the presence of 2--10 mitoses per 2 mm^2^ and/or necrosis. These changes may be focal.Representative images are shown in Fig. [6.24](#Fig24){ref-type="fig"}c--f.

**Immunohistochemistry** Immunohistochemistry is recommended for the diagnosis of neuroendocrine tumors, not only in small biopsy or cytology cases but also in resected specimens.The typical phenotype expresses neuroendocrine markers ( CD56, synaptophysin, chromogranin); most are positive for panCK and negative for high molecular weight cytokeratins (HMWCKs) and TTF1. However, TTF-1 expression was reported in 43--53% of cases.The proliferative index (ki-67) is valuable in distinguishing carcinoids from high-grade neuroendocrine carcinomas, especially in small biopsies or cytology specimens with significant crush artifact. Small cell carcinomas have high proliferative index (\>50%) in contrast to \<10--20% in carcinoids.Ki-67 is not recommended for the distinction of typical from atypical carcinoids due to the lack of cutoff value.Representative images are shown in Fig. [6.25](#Fig25){ref-type="fig"}a--d.Fig. 6.25Carcinoids, immunohistophenotype . (**a**) Positive for synaptophysin, IHC; (**b**) positive for chromogranin, IHC; (**c**) positive for AE1/3, IHC; (**d**) very low MIB-1 , IHC

##### Large Cell Neuroendocrine Carcinoma ( LCNEC) {#Sec23}

###### Key Clinical Features {#FPar39}

Heavy smokers in \>90% of cases.Paraneoplastic syndrome is uncommon.

###### Key Radiological Findings {#FPar40}

Usually a periphery mass with irregular margin, with or without intratumoral calcificationThe tumors are usually large, showing central inhomogeneous enhancement on CT with contrast.Cavitation uncommon

###### Cytological Features {#FPar41}

Overlapping with other neuroendocrine tumors and ADCsLoosely cohesive or single, monotonous tumor cells with a hyperchromatic nuclear chromatin pattern but easily appreciated nucleoli, nuclear membrane irregularity, and preserved moderate to abundant, delicate cytoplasmNecrosis or apoptotic debris may be seen.Representative images are shown in Fig. [6.26](#Fig26){ref-type="fig"}a, b.Fig. 6.26Large cell neuroendocrine carcinoma . (**a**, **b**) Loosely cohesive cluster of mildly pleomorphic tumor cells with hyperchromatic nuclear chromatin pattern but easily appreciated nucleoli, nuclear membrane irregularity, and preserved moderate to abundant, delicate cytoplasm, Diff-Quik (**a**) and Pap (**b**) stains; (**c**) large tumor cells with prominent nucleoli and moderate to abundant cytoplasm, arranged in irregular nests, H&E; (**d**) mitotic figures are easily identified, H&E

###### Differential Diagnosis {#FPar42}

Other neuroendocrine tumors, including small cell carcinomaOther non-small cell carcinomas, such as ADC, basaloid squamous cell carcinoma, and large cell carcinomaMelanomaMetastasis

###### Histology {#FPar43}

Usually arranged in typical neuroendocrine tumor growth patterns, such as organoid, trabecular, rosette-like, peripheral palisading, or solid patterns.The tumor cells are often larger, with nucleoli (often prominent) and moderate to abundant cytoplasm.Mitotic figures \>10/per 2 mm^2^ (with an average of 75) of viable tumor; tumors with \<30 mitoses/per 2 mm^2^ are rare.The proliferative index (ki-67) is usually in the range of 40--80%.Necrosis is common.Representative images are shown in Fig. [6.26](#Fig26){ref-type="fig"}c, d.

**Immunohistochemistry** Immunohistochemical markers such as synaptophysin, chromogranin, and CD56 are required to confirm neuroendocrine differentiation of the tumor.CD56 was reported in 92--100% of cases, chromogranin in 80--85%, and synaptophysin in 50--60%.About 50% of cases are positive for TTF1.PanCK, low molecular weight cytokeratin (LMWCK), and CK7 are expressed in either dot-like or diffuse cytoplasmic patterns.CD117 positivity was reported in \>70% of cases .

##### Small Cell Carcinoma {#Sec24}

###### Key Clinical Features {#FPar44}

Thirteen percent of all newly diagnosed lung cancers are small cell carcinomas.Virtually all are heavy smokers, male predominant.

###### Key Radiological Findings {#FPar45}

Usually a centrally located lobulated mass, with occasional endobrochial involvement; 5% peripherally locatedA large hilar mass with bulky mediastinal lymph nodes is characteristic; invasion of hilar vessels and vena cava is common; cavitation is rare.

###### Cytological Features {#FPar46}

Small cells with hyperchromatic nuclei, powdery chromatin texture, indistinct nucleoli, nuclear molding, and scant cytoplasmMarked mitosis and single cell necrosisNuclear debris and crush artifact in the backgroundRepresentative images are shown in Fig. [6.27](#Fig27){ref-type="fig"}a--d.Fig. 6.27Small cell carcinoma , cytology with immunophenotype. (**a**, **b**) Small uniform tumor cells with nuclear hyperchromasia, molding, powdery chromatin pattern, very scant cytoplasm, and abundant apoptotic cells, Diff-Quik; (**c**, **d**) lack of nucleoli, frequent mitoses, in clean background, Pap stain; (**e**) cellblock preparation shows thin cores of tumor tissue comprised of small, round to oval to spindled tumor nuclei with fine, granular chromatin pattern, inconspicuous nucleoli, and scant cytoplasm without defined cell borders, as well as abundant mitoses, H&E; (**f**) tumor cells are decorated by synaptophysin, IHC; (**g**) focal weak positivity with chromogranin, IHC; (**h**) diffuse nuclear staining for TTF-1, IHC; (**i**) positive CK7 staining, in a granular and dot-like pattern, IHC; (**j**) proliferative index (MIB-1 ) is estimated at 95%, IHC

###### Differential Diagnosis {#FPar47}

Reserve cell hyperplasiaCarcinoidsSmall blue cell tumors, such as lymphoma, Ewing sarcoma, and rhabdomyosarcomaNon- small cell carcinomaPulmonary blastomaMerkel cell carcinoma

###### Histology {#FPar48}

The tumor usually presents in a sheetlike pattern.The tumor cells are small, containing round, oval, or spindled nuclei, with a fine granular chromatin pattern, inconspicuous nucleoli, and scant cytoplasm, without defined cell borders.Nuclear molding is frequent.High mitotic rate is seen, at least 10 mitoses/per 2 mm^2^, with an average of 60 mitoses/per 2 mm^2^. The proliferative index (ki-67) is \>50%, with an average of \>80%.May show extensive necrosisRepresentative image is shown in Fig. [6.27e](#Fig27){ref-type="fig"}.

**Immunohistochemistry** Immunohistochemical studies may be required to confirm neuroendocrine and epithelial differentiation of the tumor.CK AE1/3, CAM5.2, and MNF116 are positive in nearly 100% of cases, with either dot-like, paranuclear, or diffuse cytoplasmic staining patterns.Neuroendocrine markers ( CD56, synaptophysin, and chromogranin) are reactive in the majority of cases; CD56 and synaptophysin are usually diffuse and strong, but chromogranin is often focal and weak.\<10% of small cell carcinomas may lack or have only very focal expression of neuroendocrine markers.TTF1 is positive in up to 90--95% of cases.CD117 positivity was reported in 60% of cases.Representative images are shown in Fig. [6.27](#Fig27){ref-type="fig"}f--j.

The features of differential diagnosis for neuroendocrine tumors are summarized in Table [6.5](#Tab5){ref-type="table"}.Table 6.5Differential diagnosis of neuroendocrine tumo rsTypical carcinoidAtypical carcinoidLCNECSCNCClinical features Age Gender Smoker6th decadeFemaleNo6th decadeFemaleVariable7th decadeMaleYes7th decadeMaleYesDiagnostic criteria Mitosis per 2 mm^2^ Necrosis Ki-67 index0--1NoUp to 5%2--10Focal if anyUp to 20%\> 10 (Med 70)Yes40--80%\> 10 (Med 80)Yes50--100%IHC  TTF1 SYN CHR  CD56Mostly --+++Mostly --++++ in 50%+ in 80--90%+ in 80--90%+ in 80--90%+ in 90--95%+ in 80--90%+ in 80--90%, F+ in 80--90%*LCNEC* large cell neuroendocrine carcinoma, *SCNC* small cell neuroendocrine carcinoma, *Med* median, *IHC* immunohistochemistry, *TTF1* thyroid transcription factor 1, *SYN* synaptophysin, *CHR* chromogranin, *CD56* cluster of differentiation 56, *F* focal

#### Large Cell Carcinoma {#Sec25}

##### Key Clinical Features {#FPar49}

About 2.3% of all pulmonary malignancies.Usually in the sixth decade, male predominant.Most patients are smokers.

##### Key Radiographic Features {#FPar50}

Chest x-ray: usually a peripheral mass, rarely may be cavitated

##### Cytological Features {#FPar51}

Single cells or loose clustersVesicular, pleomorphic nuclei with irregular nuclear membrane, multiple nucleoli and high nuclear-to-cytoplasmic ratioIll-defined, feathery cytoplasm

##### Differential Diagnosis {#FPar52}

Poorly differentiated non- small cell carcinomaMelanomaMetastatic carcinomaRadiation reactionLarge cell non-Hodgkin lymphomaAnaplastic lymphomaSarcoma

##### Histology {#FPar53}

Large cell carcinoma can only be diagnosed in a resected specimen, after ruling out the presence of squamous cell carcinoma, ADC, and small cell carcinoma morphologically, immunohistochemical evidence of squamous or ADC differentiation, and mucin stain.For small biopsy or cytology cases, large cell carcinomas can only be diagnosed as non-small cell lung carcinoma, not otherwise specified (NSCLC, NOS).Composed of sheets or nests of polygonal cells with vesicular nuclei, prominent nucleoli, and moderate amounts of cytoplasm.

**Immunohistochemistry** Immunohistochemical evaluation for TTF1, p40, and, if indicated, neuroendocrine markers ( synaptophysin, chromogranin, and CD56) to exclude the presence of ADC, squamous cell carcinoma, and high-grade neuroendocrine carcinomas (small and large cell).Only cases with negative phenotypes for those markers or cases with unclear patterns are classified as large cell carcinomas.Three subtypes of large cell carcinomas are based on immunophenotype:Large cell carcinoma with null immunohistochemical features: mucin −; cytokeratin +; TTF1 −; p63/ p40/ CK5/6 −Large cell carcinoma with unclear immunohistochemical features: mucin −; cytokeratin +; TTF1 −; p63/ p40/ CK5/6: any one of them showing focal +Large cell carcinoma with no additional stains: no immunohistochemical or mucin staining availableGenomic data are limited to marker-null large cell carcinomas. The mutations found are those showing association with ADCs, such as *KRAS* and occasional *EGFR*. *TP53* mutations, *CDKN2A* deletions, and *MYC* as well as cyclin E1 (*CCNE1)* amplifications are also reported, with a similar frequency to that of other histological types. Therefore, molecular testing is recommended for large cell carcinomas .

#### Sarcomatoid Carcinoma {#Sec26}

Sarcomatoid carcinoma is a general term that includes pleomorphic carcinoma, carcinosarcoma, and pulmonary blastoma, which are individual entities in the 2015 WHO classification. This group of tumors accounts for 2--3% of all cancer cases in a surgical series and \<1% of all lung cancers. Definitive diagnosis of this group of tumors is very difficult or impossible in small biopsies and cytology specimens.

The characteristic features of individual tumors in this group are summarized in Table [6.6](#Tab6){ref-type="table"}.Table 6.6Features of sarcomatoid carcinom asPleomorphic, spindle cell, and giant cell CACarcinosarcomaPulmonary blastom aClinical featuresOften smokersOften heavy smokersMen \> women, 7--8 timesMedian age of 65 yearsOften smokersNo sex predominanceCommon in the fifth decadeRadiographic featuresA large peripheral mass, favoring the upper lobes; CT: low central attenuation, with frequent invading to adjacent pleura.Usually centrally located mass with necrosisUsually solitary, large, peripherally located massCytologic features1. Both malignant epithelial (ADC or SqCC) and mesenchymal-like elements2. Discohesive, round to oval tumor giant cells with single or multiple large, irregular, lobulated nuclei, and abundant eosinophilic cytoplasm3. Collagen or myxoid stroma, mitosis, necrosis, lymphocytes, and neutrophils1. Both malignant epithelial and mesenchymal elements2. The epithelial component is often SqCC with marked keratinization3. The mesenchymal component can be heterologous differentiation1. Biphasic tumor with fetal ADC (LG) and primitive mesenchymal stroma2. Fetal ADC: uniform, small columnar cells with small nuclei, inconspicuous nucleoli and clear vacuolated cytoplasm3. Stroma: loose aggregate or single dispersed small homogeneous cells with oval to elongated nuclei without nucleoli and high N/C ratio; may be embedded in myxoid tissue fragment4. Reticulated, bubbly backgroundHistology1. Pleomorphic CA: a mixture of giant and/or spindle cell elements (at least 10%) and epithelial elements, commonly ADC (31--72%), followed by undifferentiated NSCC (up to 43%) and SqCC (12--26%)2. Spindle cell CA: composed of almost entirely malignant spindle cells in fascicular or storiform patterns3. Giant cell CA: composed almost entirely pleomorphic giant tumor cells1. Feature intimately admixed NSCC and sarcoma2. The NSCLC component is often SqCC, followed by ADC, adenosquamous CA, and large cell CA3. The sarcomatous components include, in descending order of frequency, rhabdomyosarcoma, chondrosarcoma, and osteosarcoma; often in combination1. Areas of epithelial and mesenchymal differentiation in various proportions2. Epithelial element: essentially LG fetal ADC, composed of branching tubules or glandular structures lined by pseudostratified columnar cells with bland morphology and clear to weakly eosinophilic cytoplasm3. Mesenchymal element: tightly packed primitive cells with oval or elongated nuclei and high N/C ratio in myxoid or fibrous background; heterologous elements may be seenImmunohistochemistry1. Positive for vimentin and fascin2. Epithelial elements: positive for corresponding differentiation markers3. Keratin expression is not required in giant or spindle cell elements1. Helpful to highlight the epithelial and sarcomatous differentiation2. The NSCLC component express markers of the conventional count parts3. The sarcomatous component expresses corresponding linage markers1. Epithelial element: positive for CK7, CK AE1/3, CEA, EMA, and TTF1; focally positive for CHR, SYN, and vimentin2. Mesenchymal element: positive for vimentin, MSA, focal to CK AE1/3; heterologous elements: positive for linage specific markers3. N/C accumulation of β-catenin: both epithelial and mesenchymal elementsMolecular Genetics*KRAS* mutation in up to 38% of cases; *EGFR* mutation in up to 25% of cases;*TP53* mutation in spindle cell and pleomorphic CAsFrequent for *TP53* mutationLess frequent for *KRAS* mutationVery uncommon for *EGFR* mutationFrequent missense mutations in exon 3 of *CTNNB1TP53* mutation and both p53 and MDM2 protein accumulation occasionally detected*CA* carcinoma, *CT* computed tomography, *ADC* adenocarcinoma, *SqCC* squamous cell carcinoma, *LG* low-grade, *N/C* nuclear to cytoplasmic ratio, *NSCC* non- small cell carcinoma, *NSCLC* non-small cell lung carcinoma, *CK* cytokeratin, *CEA* carcinoembryonic antigen, *EMA* epithelial membrane antigen, *TTF1* thyroid transcription factor 1, *CHR* chromogranin, *SYN* synaptophysin, *MSA* muscle-specific actin, *KRAS* Kirsten rat sarcoma oncogene, *EGFR* epithelial growth factor receptor, *TP53* tumor protein 53, *CTNNB1* catenin beta 1, *MDM2* mouse double minute 2 homolog

Representative images are illustrated in Fig. [6.28](#Fig28){ref-type="fig"}a--h. Fig. 6.28Pleomorphic , spindle cell and giant cell carcinoma. (**a**, **b**) Discohesive, round to oval tumor giant cells with multiple large, irregular, lobulated nuclei and abundant eosinophilic cytoplasm, rare squamoid cells, and neutrophils are present, Diff-Quik; (**c**, **d**) spindled and giant tumor cells, Pap stain; (**e**) focal squamous differentiation is seen; spindled and giant tumor cells with abundant mitoses and necrosis (not shown), H&E; (**f**) vimentin positive, IHC; (**g**) AE1/3 positive, IHC; (**h**) focal CK5/6 positive, IHC

#### Nuclear Protein in Testis (NUT) Carcinoma {#Sec27}

This is a new entity in the 2015 WHO classification of tumors of lung. The group of carcinomas associated with chromosomal rearrangement in the *NUT* gene is designated as NUT carcinoma.

##### Key Clinical Features {#FPar54}

Affects people of all ages, although, it was originally reported in children and younger adultsMale equals femaleFewer than 100 cases reportedUsually presents at an advanced stage, with pleural effusion, chest pain, weight loss, and respiratory symptoms

##### Key Radiological Features {#FPar55}

Chest x-ray: extremely rapid-growing tumor, with complete opacification of the thorax within 2--8 weeksCT: a hypoattenuating, heterogeneously enhancing, often extensively necrotic mass with poorly defined, infiltrative borders. High fluorodeoxyglucose (FDG) uptake is characteristic.

##### Cytologic Findings {#FPar56}

Usually cellular smearsDiscohesive clusters and single of small to intermediate size, monomorphic cells with irregular nuclear membrane, granular to coarse chromatin pattern, and discrete nucleoliMitoses, necrotic debris, and crush artifact are common.Representative image is shown in Fig. [6.29a](#Fig29){ref-type="fig"}.Fig. 6.29NUT carcinoma . (**a**) Highly cellular smears contain discohesive clusters and single of small to intermediate sized, monomorphic cells, Diff-Quik; (**b**) sheets of small- to intermediate-sized, primitive-appearing cells with distinct nucleoli, granular to coarse chromatin, and pale eosinophilic to basophilic cytoplasm, H&E

##### Differential Diagnosis {#FPar57}

Poorly differentiated malignant neoplasmsBasaloid squamous cell carcinomaSmall cell carcinomaEwing sarcomaGerm cell tumorAcute leukemia

##### Histology {#FPar58}

NUT carcinoma, also known as NUT midline carcinomaUsually composed of sheets and nests of small- to intermediate-size undifferentiated cells with a monomorphic appearanceThe tumor cells are primitive-appearing, with irregular nuclear membrane, distinct nucleoli, granular to coarse chromatin, and pale eosinophilic to basophilic cytoplasm.Neutrophil infiltration is a prominent feature.Foci of abrupt keratinization are characteristic.Representative image is shown in Fig. [6.29b](#Fig29){ref-type="fig"}.

**Immunohistochemistry** Speckled nuclear positivity in more than 50% of tumor cells with NUT antibody is a constant finding and is diagnostic.Broad-spectrum cytokeratins are positive in majority of cases.Other epithelial markers, such as epithelial membrane antigen (EMA), epithelial cell adhesion molecule (BerEP4), and carcinoembryonic (CEA) antigen showed variable results.Most of cases are positive for p63/ p40 and CD34.Occasional reactivity to synaptophysin, chromogranin, and even TTF1 was observed.NUT carcinomas are defined by the presence of NUT gene rearrangement, which is a chromosomal translocation between the *NUT* gene (*NUTM1*) on chromosome 15q14 and other genes: Bromodomain containing *4* (*BRD4*) on chromosome 19p13.1 (70%), *BRD3* on chromosome 9q34.2 (6%), or an unknown partner gene (24%).

#### Metastasis to the Lung (See Chap. 10.1007/978-3-319-57386-1_7 on the Liver and Other Chapters) {#Sec28}

The most common metastatic tumors are carcinomas, especially from the gastrointestinal tract, gynecological tract, breast, urothelial, head and neck, prostate, and other sites, followed by sarcomas, melanomas, and germ cell tumors. Sex and age distribution depend on tumor types, such as colorectal cancers in elderly patients of both sexes, breast cancer and melanoma in younger adults, and germ cell tumors and sarcomas in young adults or children. Metastases can be single or multiple, usually involving the lung parenchyma and the pleura. However, bilateral, multiple, peripherally located round, variable-size nodules (hematogenous metastases), or diffuse thickening of the interstitium (lymphangitic carcinomatosis) are typical.

Cytological features, histological findings, and immunoprofile are the same as the primary tumors. The differential immunophenotypes for the most common metastatic carcinomas are summarized in Table [6.7](#Tab7){ref-type="table"}.Table 6.7Typical immunophenotypes of the common metastatic carcinomasAntibodyUpper GILower GIBreastGYNThyroidProstateUrinary BladderCK7+−+++−+CK20+/−+−−/+−−+/−TTF1−−−−+−−PAX8−−−++−−GATA3−−+−−−+ER−−+/−+−−−SATB2−+−−−−−NKX3.1−−−−−+−Thyroglobulin−−−−+−−p63−−−−−−+/−CK5/6−−−/+, F−−−+− positive in \<5% of cells, + positive in \>70% of cells, +/− positive in 50--70% of cells, −/+ positive in \<50% of cells*GI* gastrointestinal tract, *GYN* gynecologic, *CK* cytokeratin, *TTF1* thyroid transcription factor-1, *PAX8* paired box gene 8, *GATA3* GATA binding protein 3, *ER* estrogen receptor, *SATB2* special AT-rich sequence-binding protein 2, *NKX3.1* NK3 homeobox 1, *F* focal

Pleura {#Sec29}
======

The WHO classifications of tumors of the pleura, 2015, are summarized in Table [6.8](#Tab8){ref-type="table"}.Table 6.82015 World Health Organization (WHO) classification of tumors of the pleura*Mesothelial tumors*Diffuse malignant mesothelioma  Epithelioid mesothelioma  Sarcomatoid mesothelioma  Desmoplastic mesothelioma  Biphasic mesotheliomaLocalized malignant mesothelioma  Epithelioid mesothelioma  Sarcomatoid mesothelioma  Biphasic mesotheliomaWell-differentiated papillary mesotheliomaAdenomatoid tumor*Lymphoproliferative disorders*Primary effusion lymphomaDiffuse large B-cell lymphoma associated with chronic inflammation*Mesenchymal tumors*Epithelioid hemangioendotheliomaAngiosarcomaSynovial sarcomaSolitary fibrous tumor  Malignant solitary fibrous tumorDesmoid-type fibromatosisCalcifying fibrous tumorDesmoplastic round cell tumorUsed with permission from Travis WD, Brambilla E, Burke AP, Marx A, Nicholson A. WHO classification of tumors of the lung, pleura, thymus, and heart. Lyon, France: IARC; 2015

Mesothelioma {#Sec30}
------------

### Key Clinical Features {#FPar59}

Usually occurs in older adults, ≥60 yearsMore often in menA strong association with asbestos exposurePleural effusion is very common.

### Key Radiological Features {#FPar60}

Variety of presentations, classically exhibiting a diffuse circumferential ring of nodular pleura associated with ipsilateral effusionLess commonly presents with pleural effusion without obvious pleural nodularityPleural plaques, especially associated with calcifications, are suggestive of asbestos exposure.

### Cytological Features {#FPar61}

Hypercellular specimen with mixed epithelial and spindle cells.Can be epithelial or spindle cell dominate.Resemble ordinary mesothelial cells.Tumor giant cells, granulomas, and psammoma can be seen.Representative images are shown in Fig. [6.30](#Fig30){ref-type="fig"}a--c.Fig. 6.30Mesothelioma cytology and histopathology. (**a**) Cellular smears contain single and loosely clusters of plump and spindled cells, Pap stain; (**b**) epithelioid cells in papillary configuration, Diff-Quik; (**c**) atypical epithelioid cells, Diff-Quik; (**d**) histopathology, mesothelioma in nested pattern infiltrating dense fibrous tissue, H&E; (**e**) histopathology, perineural invasion, H&E; (**f**) histopathology, mesothelioma with papillary pattern, H&E

### Differential Diagnosis {#FPar62}

Pulmonary ADC (Table [6.9](#Tab9){ref-type="table"})Table 6.9Distinction of lung adenocarcinoma from mesotheliomaMarkersMesotheliomaAdenocarcinomaCalretinin+−Cytokeratin 5/6+−WT1+−D2--40+−MOC-31−+CEA−+TTF1−+LeuM1−+BerEP4−+B72.3−+"+" positive in majority of cases, "-" negative in majority of casesNote: Two positive markers and two negative markers are usually needed to make a diagnosis of mesothelioma: (1) Two positive markers: calretinin and cytokeratin 5/6 (or Wilms tumor 1\[WT1\]); (2) two negative markers: CEA and MOC-31 (or B72.3)*WT1* Wilms tumor 1, *D2--40* podoplanin, *MOC-31* epithelial-related antigen, *CEA* carcinoembryonic antigen, *TTF1* thyroid transcription factor 1, *LeuM1* cluster of differentiation (CD)15, *BerEP4* epithelial cell adhesion molecule, *B72.3* tumor-associated glycopotein (TAG)72Metastatic carcinomaReactive mesothelial cells (Table [6.10](#Tab10){ref-type="table"})Table 6.10Benign mesothelial cells vs. mesotheliomaMarkersBenign mesothelial cellsMesotheliomaGLUT1−/++CD146--+IMP3−/++E-Cadherin--+EMA+/−+p53−/++Desmin+−/+p16+/−−/+-- positive in \<5% of cells, + positive in \>70% of cells, +/− positive in 50--70% of cells, −/+ positive in \<50% of cells*GLUT1* glucose transporter 1, *CD146* cluster of differentiation 146, *IMP3* insulin-like growth factor II messenger RNA binding protein-3, *EMA* epithelial membrane antigen

### Histology {#FPar63}

*Epithelioid Mesotheliomas* Account for 60--80% of malignant mesotheliomasVariety of histological patterns. Most common patterns: solid, tubulopapillary, and trabecular; less common patterns: micropapillary, adenomatoid (microcystic), clear cell, transitional, deciduoid, and small cellThe tumor cells are usually bland, with eosinophilic cytoplasm and a bland vesicular chromatin pattern. Occasional anaplastic forms may be observed.The fibrous stroma can vary from scant to prominent, showing varying degree of cellularity from hyalinized acellular to highly cellular stroma. Myxoid changes may be seen in 5--10% of cases, with nests of bland-looking, vacuolated epithelioid cells floating in the matrix.Representative images are shown in Fig. [6.30](#Fig30){ref-type="fig"}d--f.

**Sarcomatoid Mesotheliomas** Characterized by a proliferation of spindle cells arranged in fascicles or with a haphazard pattern and involves the adipose tissue of the parietal pleura or the adjacent lung parenchyma.The tumor cells show variety of morphology, from plump to thin, elongated cells with scant cytoplasm.The degree of nuclear atypia, mitotic activity, and necrosis vary from minimal to moderate to marked .

**Desmoplastic Mesotheliomas** Characterized by areas of atypical spindle cells arranged in a so-called patternless pattern within a dense, hyalinized, fibrous stroma constituting at least 50% of the tumorInvasion of adipose tissue is the most reliable criterion to distinguish desmoplastic mesothelioma from organizing pleuritis.

**Biphasic Mesotheliomas** Show any combination of the patterns described above constituting at least 10% of the tumor

**Immunohistochemistry** Positive for CK AE1/3, calretinin, CK5/6, WT1, and D2--40.Negative for BerEP4, MOC-31, B72.3, and CEA.See Tables [6.8](#Tab8){ref-type="table"} and [6.9](#Tab9){ref-type="table"} for differential diagnosis.Multiple chromosomal alterations, more common with chromosomal losses, especially on chromosomal arms 1p, 3p, 4q, 6q, 9p, 13q, 14q, and 22q; alterations in several tumor suppressor genes, including neurofibromin 2 (NF2), CDKN2A (p16INK4a), CDKN2B (p15INK4b), and BRCA1-associated protein 1 (BAP1).Representative images are shown in Fig. [6.31](#Fig31){ref-type="fig"}a--f.Fig. 6.31Mesothelioma , immunophenotype. (**a**) Calretinin decorates tumor cells, IHC; (**b**) positive for WT-1, IHC; (**c**) CK5/6 positive, IHC; (**d**) positive for GLUT1, IHC; (**e**) positive for AE1/3, IHC; (**f**) MOC31 negative, IHC

Mesenchymal Tumors {#Sec31}
------------------

### Solitary Fibrous Tumor {#Sec32}

#### Key Clinical Features {#FPar64}

Most common in sixth to seventh decadesNo sex predispositionAccounting for \<5% of primary pleural tumorsUnknown etiologySlow-growing, relatively benign tumors, up to 10% malignantUsually asymptomatic, incidental finding

#### Key Radiological Features {#FPar65}

Usually solitary, well-circumscribed mass arising from visceral pleuraCan be multiple and distributed throughout the pleural cavity

#### Cytological Features {#FPar66}

Cellular smear with bland-appearing, small, oval to spindled cellsNo mitosis or necrosisRepresentative images are shown in Fig. [6.32a](#Fig32){ref-type="fig"}, b.Fig. 6.32Solitary fibrous tumor . (**a**, **b**) Cellular smear with bland-appearing, small, oval to spindled cells, Pap stain; (**c**, **d**) surgical resection tissue showing patternless spindle cells with significant hyalinized stroma, H&E; (**e**) diffuse CD34 positivity, IHC; (**f**) positive for STAT6, IHC

#### Differential Diagnosis {#FPar67}

Neuroendocrine tumorsSynovial sarcomaSarcomatoid mesotheliomaNerve sheath tumorType A thymoma

#### Histology {#FPar68}

Uniform fibroblastic spindle cells with tapering nuclei, scant, pale, indistinct cytoplasm, variable cellularity, and patternless architecture.Focal storiform or fascicular growth pattern may be seen.Prominent stromal and perivascular hyalinization.Branching hemangiopericytoma-like vessels of varying size and number.Usually \<3 mitoses/per 2 mm^2^; malignant: \> 4 mitoses/per 2 mm^2^, rarely showing dedifferentiation.Representative images are shown in Fig. [6.32](#Fig32){ref-type="fig"}c, d.

**Immunohistochemistry** Positive for signal transducer and activator of transcription 6 (STAT6): \> 95% of cases, specific.Positive for CD34, B-cell CLL/lymphoma 2 (Bcl2), and CD99: nonspecific.Occasionally may be positive for SMA, epithelial membrane antigen (EMA), keratin, S100, or desmin.Representative images are shown in Fig. [6.32](#Fig32){ref-type="fig"}e, f.The tumor harbors characteristic gene fusion NGFI-A binding protein 2 (*NAB2)-STAT6* .

Mediastinum {#Sec33}
===========

Overview {#Sec34}
--------

The mediastinum can be divided into four hypothetical compartments: superior, anterior, middle, and posterior. The distribution of organs and tumors of the mediastinum is summarized in Table [6.11](#Tab11){ref-type="table"}.Table 6.11Distribution of organs and tumors of the mediastinumSuperior*Thymus* (thymoma, cyst, carcinoid, lymphoma)*Lymph node* (metastases, lymphoma, inflammation)*Thyroid* (goiter, neoplasm)*Parathyroid* (adenoma, cyst)*Other* (cysts, aneurysm)Anterior*Thymus* (thymoma, cyst, carcinoid, lymphoma)*Germ cell tumorsLymph node* (metastases, lymphoma, inflammation)*Thyroid* (goiter, neoplasm)*Parathyroid* (adenoma, cyst)*Paraganglia tumorsOther* (angioma, lipoma, other mesenchymal tumorsMiddle*Cysts* (pericardial, bronchogenic)*Lymph node* (metastases, lymphoma, inflammation)*Other* (atrial myxoma, mediastinal fibrosis)Posterior*Neurogenic* (nerve sheath and sympathetic, paraganglioma)*Lymph node* (metastases, lymphoma, inflammation)*Cyst* (gastroenteric)*Other* (esophageal lesions, abscess, aneurysm, meningocele)

In adults, the distribution of tumors is as follows: 46% thymic epithelial tumors, 23% lymphomas, 16% endocrine tumors, and 15% germ cell tumors. In children, the frequency of tumors is 47% neurogenic neoplasms, 19% germ cell tumors, 12% lymphomas, 10% thymic epithelial tumors, 6% cysts, and 6% mesenchymal tumors. The 2015 WHO classification of tumors of the thymus is summarized in Table [6.12](#Tab12){ref-type="table"}.Table 6.122015 World Health Organization (WHO) classification of tumors of the thymus*Epithelial tumors*Thymoma Type A thymoma, including atypical variant Type AB thymoma Type B1 thymoma Type B2 thymoma Type B3 thymoma Micronodular thymoma with lymphoid stroma Metaplastic thymoma Other rare thymoma Microscopic thymoma Sclerosing thymoma LipofibroadenomaThymic carcinoma  Squamous cell carcinoma Basaloid carcinoma  Mucoepidermoid carcinoma  Lymphoepithelioma-like carcinoma Clear cell carcinoma Sarcomatoid carcinoma Adenocarcinomas   Papillary adenocarcinoma  Thymic carcinoma with adenoid cystic carcinoma-like features  Mucinous adenocarcinoma Adenocarcinoma, not otherwise specified (NOS)Thymic carcinoma (continued) NUT carcinoma Undifferentiated carcinoma Other rare thymic carcinomas  Adenosquamous carcinoma Hepatoid carcinoma Thymic carcinoma, NOSThymic neuroendocrine tumors  Carcinoid tumors Typical carcinoid Atypical carcinoid  Large cell neuroendocrine carcinoma  Combined large cell neuroendocrine carcino ma  Small cell carcinoma   Combined small cell carcinomaCombined thymic carcinomas*Germ cell tumors* *of the mediastinum*SeminomaEmbryonal carcinomaYolk sac tumorChoriocarcinomaTeratoma Teratoma, mature Teratoma, immatureMixed germ cell tumorsGerm cell tumors with somatic-type solid malignancyGerm cell tumors with associated hematological malignancy*Lymphomas of the mediastinum*Primary mediastinal large B-cell lymphomaExtranodal marginal zone lymphoma ofmucosa-associated lymphoid tissue(MALT lymphoma)Other mature B-cell lymphomasT lymphoblastic leukemia/lymphomaAnaplastic large cell lymphoma (ALCL) and other rare mature T- and natural killer (NK)-cell lymphomas ALCL, ALK-positive (ALK+) ALCL, ALK-negative (ALK-)Hodgkin lymphomaB-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and classical Hodgkin lymphoma*Histiocytic and dendritic cell neoplasms of the mediastinum*Langerhans cell lesionsThymic Langerhans cell histiocytosisLangerhans cell sarcomaHistiocytic sarcomaFollicular dendritic cell sarcomaInterdigitating dendritic cell sarcomaFibroblastic reticular cell tumorIndeterminate dendritic cell tumor*Myeloid sarcoma and extramedullary acute myeloid leukemiaSoft tissue tumors of the mediastinum*ThymolipomaLipomaLiposarcoma Well-differentiated Dedifferentiated Myxoid PleomorphicSolitary fibrous tumor MalignantSynovial sarcoma  Synovial sarcoma, NOS  Synovial sarcoma, spindle cell  Synovial sarcoma, epithelioid cell  Synovial sarcoma, biphasicVascular neoplasms Lymphangioma Hemangioma  Epithelioid hemangioendothelioma  AngiosarcomaNeurogenic tumors Tumors of peripheral nerves Ganglioneuroma Ganglioneuroblastoma Neuroblastoma*Ectopic tumors of the thymus*Ectopic thyroid tumorsEctopic parathyroid tumorsOther rare ectopic tumorsUsed with permission from Travis WD, Brambilla E, Burke AP, Marx A, Nicholson A. WHO classification of tumors of the lung, pleura, thymus, and heart. Lyon, France: IARC; 2015

Selected entities will be discussed in the section below.

### Cysts {#Sec35}

#### Key Clinical Features {#FPar69}

Bronchogenic cyst --any part of the mediastinumEnteric cyst -- posterior mediastinumThymic cyst -- anterior mediastinumPericardial cyst --middle mediastinum

#### Cytological Features {#FPar70}

Hypocellular smearDependent upon the type of the cyst

### Epithelial Tumors {#Sec36}

#### Thymoma {#Sec37}

##### Key Clinical Features {#FPar71}

Rare malignancy overall, but the most common mediastinal tumors in adultsMedian age of 50 years, rare in childrenMay present as a mass lesion or an incidental findingMay be associated with myasthenia gravis, pure red cell aplasia, hypogammaglobulinemia (Good syndrome), and/or other autoimmune disorders

##### Key Radiological Features {#FPar72}

Usually a mass lesion, well-circumscribed or invasive borders, depending on the subtypes of thymoma

##### Cytological Features {#FPar73}

Usually moderate to hypercellular smearTwo populations of relatively bland neoplastic epithelial cells and lymphocytesThe proportion of epithelial cells and lymphocytes is dependent upon subtype.In epithelial subtype, epithelial cells are dominant; in lymphocyte-predominant subtype, small mature lymphocytes are dominant; and in spindle cell type, spindle epithelial cells are predominant.Neoplastic epithelial cells tend to be cohesive and have a delicate nuclear membrane, fine nuclear chromatin, and small nucleoli.Few or no mitoses are present.Representative images are shown in Fig. [6.33](#Fig33){ref-type="fig"}a--f.Fig. 6.33Thymoma, cytology. (**a**, **b**) Epithelial prominence, showing round to slightly oval nuclei with vesicular chromatin and small but prominent nucleoli, Diff-Quik (**a**) and Pap (**b**) stains; (**c**) spindle cell predominant, bland-appearing, Pap stains; (**d**) mixed epithelial and lymphocytes, Diff-Quik; (**e**, **f**) lymphocyte predominant, Diff-Quick (E) and Pap (F) stains

##### Differential Diagnosis {#FPar74}

Thymic carcinomaThymic hyperplasiaT-cell lymphoblastic lymphomaNeuroendocrine neoplasm

##### Histology {#FPar75}

Type A thymoma: Complete or incomplete fibrous capsule may display coarse lobulation with thick fibrous bands.Microcystic pattern is most common, more prominent in subcapsular areas.Other patterns: rosettes (with or without a central lumen), glandular or glomeruloid structures, Masson's hemangioma-like papillary projections in cystic spaces, meningioma-like whorls, fascicular growth, and storiform growth.Hassall corpuscles are absent.The tumor cells are spindled and/or oval-shaped with bland nuclei, finely dispersed powdery chromatin, and inconspicuous nucleoli.Low mitotic activity, usually \<4 mitoses/per 2 mm^2^.No or very few immature lymphocytes.When hypercellularity, increased mitotic counts, and focal necrosis are present, designate as atypical type A thymoma variant.Representative images are shown in Fig. [6.34](#Fig34){ref-type="fig"}a, b.Fig. 6.34Thymoma , histopathology. (**a**) Spindle cell predominant, type A, H&E; (**b**) type A, microcystic growth pattern, H&E; (**c**) lymphocyte-predominant, individual embedded epithelial tumor cells, type B1, H&E; (**d**) type B1, pale-stained medullary island left lower corner), H&E; (**e**) cytokeratin AE1/3 decorates tumor epithelial cells, IHC; (**f**) p63 positive in epithelial tumor cells, IHC; (**g**) TdT-positive mature T lymphocytes, IHC; (**h**) positive for CD5, mature T lymphocytes, IHCType AB thymoma: Well-demarcated and encapsulated tumor showing a lobulated growth pattern.Highly variable mixture of a lymphocyte-poor type A component and a more lymphocyte-rich type B-like component including a prominent infiltrate (often in dense clusters) of immature, TdT+ T cells. Infiltrate of TdT+ lymphocytes in \>10% of the tumor area is a feature used to distinguish from type A thymoma.The tumor cells are small, oval to plump, spindled, or polygonal shaped, containing round to oval pale-staining nuclei showing dispersed chromatin and inconspicuous nucleoli.Medullary islands are very rare; Hassall corpuscles are absent.Summary of three distinctive features of type AB thymoma: (a) an admixed spindle cell-predominant, lymphocyte-poor component and lymphocyte-rich component; (b) bland, spindly, oval, and focally polygonal thymic epithelial cells; and (c) a focal or diffuse abundance of immature T cells .Type B1 thymoma :Thymus-like architecture with predominance of cortical areas.Either absence of lobulation or lobulated with larger lobules traversed by hypocellular, collagenous septa.The neoplastic epithelial cells are individually embedded in densely packed nonneoplastic immature lymphocytes; the epithelial cells have poorly defined, pale eosinophilic cytoplasm, and relatively uniform, oval to slightly irregular round nuclei, showing pale chromatin, distinct nuclear membranes, and small central nucleoli.Medullary islands are always present and may contain Hassall corpuscles and myoid cells; perivascular spaces are often seen.Summary of two distinctive features of type B1 thymoma: (a) close resemblance to the normal, non-involuted thymic cortex; (b) the consistent presence of medullary islands.Representative images are shown in Fig. [6.34](#Fig34){ref-type="fig"}c, d.Type B2 thymoma :Encapsulated tumor, composed of lymphocyte- predominant, irregular size and shape tumor lobules surrounded by delicate fibrous septa, giving a lobular architecture and blue appearance on hematoxylin and eosin (H&E) stain.Interspersed among the lymphoid cells are single or poorly defined clusters of epithelial cells (≥ 3 cells).The epithelial cells have round or slightly oval nuclei with vesicular chromatin and small but prominent nucleoli; rare focal anaplasia may be seen.Perivascular spaces composed of a central venule surrounded by a clear space containing proteinaceous fluid or lymphocytes.Hassall corpuscles are rare; medullary islands are uncommon.Summary of distinctive features of type B2 thymoma: (a) polygonal (non-spindle shaped) neoplastic thymic epithelial cells in clusters; (b) high content of intermingled immature T cells .Type B3 thymoma :Tumor lobules separated by fibrous septa, pushing borders at the invasion front, prominent perivascular spaces with epithelial palisading, rare Hassall corpuscles.Tumor cells are polygonal with eosinophilic or clear cytoplasm and slightly/moderately atypical, round to elongated, grooved, or raisinoid nuclei.Summary of distinctive features of type B3 thymoma: (a) predominance of polygonal epithelial cells forming solid sheets, resulting in a pink appearance on H&E; (b) paucity of admixed nonneoplastic immature T cells .

**Immunohistochemistry** Epithelial cells: usually positive for AE1/3, CK7, CK19, p63, PAX8, forkhead box N1 (FOXN1), CD57, and CD205; negative for EMA, CD117, and CD5.Small lymphocytes (thymocytes) are mature T-cells, but positive for CD3, CD5, TdT, CD99, with a high MIB1 (Ki-67) proliferative index.Representative images are shown in Fig. [6.34](#Fig34){ref-type="fig"}e--h.

#### Thymic Carcinomas {#Sec38}

Thymic carcinomas include of a variety of histological types of tumors, accounting for approximately 22% of all thymic epithelial neoplasms. The squamous cell carcinomas are the most common type, accounting for approximately 70% of all thymic carcinoma cases. Lymphoepithelioma-like carcinomas are rare, accounting for 6--32% of all thymic carcinomas; sarcomatoid carcinomas account for 5--10%; and basaloid carcinomas account for \<5%. Other types, such as mucoepidermoid carcinomas, clear cell carcinomas, ADCs, NUT carcinomas, and undifferentiated carcinomas, are very few. The characteristic features of the three most common types are summarized in Table [6.13](#Tab13){ref-type="table"}.Table 6.13Features of thymic carcinomas of the most common typesSquamous cell carcino maLymphoepithelioma-like carcino maSarcomatoid carcinomaClinical features1. 70% of all cases2. Most common in sixth decade3. Men slightly more than women4. \<5% associated with myasthenia gravis1. 6--32% of all cases2. Median age: 41; bimodal peaks at 14 and 48 years3. Male/female: 2:14. Association with EBV in \~50% of cases, especially in children and young adults1. 5--10% of all cases2. In late adulthood, fourth--eighth decades, mean 47 years3. Unknown etiologyRadiographic featuresUsually an anterior mediastinal mass, often with poorly defined, irregular lobular margins, or with necrotic/cystic changes, which on CT appear as low-attenuation regions, on MRI with greater tumor heterogeneity1. a large mass in the anterior mediastinum with necrosis (low-attenuation on CT)2. Often invading surrounding tissues: pleura, lung, diaphragm, and pericardium1. Usually a large, lobulated mass in the anterior mediastinum with necrosis (low-attenuation on CT)2. Often invading surrounding tissues: pleura, lung, diaphragm, and pericardium; with encroachment on the major vesselsCytologic featuresSingle or clusters of large atypical cells with enlarged nuclei showing coarse chromatin and macronucleoli and a moderate amount of cytoplasm (Fig. [6.35](#Fig35){ref-type="fig"})1. Malignant epithelial cells: clusters of large, relatively uniform cells with vesicular nuclei, one or more distinct nucleoli, indistinct cell borders; polygonal squamoid cells in some2. Many lymphocytes and plasma cells1. Type A thymoma component: spindled epithelial cells with bland nuclei, powdery chromatin, and inconspicuous nucleoli2. Malignant spindle cells: coarse chromatin, prominent nucleoli, and frequent mitoses; may show heterologous sarcomatous fragmentsHistology1. Infiltrative, usually smooth contoured sheets, islands, and cords of large polygonal cells accompanied by broad zones of desmoplastic to sclerohyaline stroma2. Polygonal tumor cells: large vesicular or hyperchromatic nuclei, distinct nucleoli, eosinophilic cytoplasm, and vague to obvious intercellular bridges; may be keratinized with keratin whorls mimic Hassall corpuscles3. Foci of coagulative necrosis are common1. Anastomosing sheets, nests, and cords of CA cells accompanied by dense lymphocytes and plasma cells2. CA cells: large vesicular nuclei, one or more distinct nucleoli, and indistinct cell borders; the nuclei are relatively uniform, crowded, overlapping3. Focal squamous differentiation4. Coagulative necrosis5. Many lymphocytes and plasma cells; may see germinal center, eosinophils, and granulomas1. Usually a mixture of conventional type A thymoma and areas of malignant spindle cells2. Gradual or abrupt transition between the two3. Malignant cells: coarse chromatin. Prominent nucleoli, frequent mitoses4. May see small areas of lymphoepithelioma-like CA or prominent squamous differentiation5. May have heterologous mesenchymal elementsIHC1. Positive for CKs, p63 (83%), PAX8 (\~75%);CD5, CD117, GLUT1, and MUC1 (\~80%); FOXN1 (68--76%), CD205 (10--59%)2. Focal expression of NE markers: 64% cases3. Lack TdT+ lymphocytes1. for panCKs, p63, CD117, and CD5 (variable)2. Negative for CK7 and CK203. Admixed CD3+/ TdT- T cells and B cells; the plasma cells are polytypic for Ig.1. Type A thymoma component: same as conventional2. Malignant spindle cells: positive for CK, EMA; may or may not be CD5-positive3. The heterologous sarcomatous elements express markers for their differentiationMolecular Genetics1. Chromosomes loss (16q, 6, 3p, and 17p); gain (1q, 17q, and 18)2. Mutations of *KIT* (11%), *TP53* (\~20%)4. Copy number gain of *Bcl2*, loss of *p16* *(CDKN2A)*5. Missense mutation of *GTF2I* gene: \<10%1. EBV is almost always positive in children and young adults, uncommon positive in adults \>30 years2. The most reliable test: in situ hybridization for EBV-encoded small RNAInformation limited*EBV* Epstein-Barr virus, *CT* computed tomography, *MRI* magnetic resonance imaging, *CA* carcinoma, *IHC* immunohistochemistry, *CK(s)* cytokeratin(s), *CD* cluster of differentiation, *GLUT1* glucose transporter 1, *MUC1* mucin 1, *FOXN1* forkhead box N1, *NE* neuroendocrine, *TdT* terminal deoxynucleotidyl transferase, *Ig* immunoglobulin, *EMA* epithelial membrane antigen, *KIT* a type III transmembrane receptor tyrosine kinase, *TP53* tumor protein 53, *Bcl2* B-cell CLL/lymphoma 2, *CDKN2A* cyclin-dependent kinase inhibitor 2A, *GTF2I* general transcription factor IIi, *RNA* ribonucleic acid Fig. 6.35Thymic carcinoma, showing single and clusters of large atypical cells with enlarged nuclei, coarse chromatin, macronucleoli, and moderate amount of cytoplasm, Pap stain

#### Thymic Neuroendocrine Tumors {#Sec39}

Thymic neuroendocrine tumors are categorized into two major groups: (1) low-grade typical carcinoids and intermediate-grade atypical carcinoids, which always show characteristic morphological and immunohistochemical neuroendocrine features, and (2) high-grade LCNECs and small cell carcinomas, which may lack some neuroendocrine features.

##### Key Clinical Features {#FPar76}

No established association with smoking.More aggressive clinical course: propensity for recurrence, lymph node or distant metastases, and tumor-associated death.Atypical carcinoids account for the majority of the tumors.Only carcinoids reported in setting of multiple endocrine neoplasia type 1 (MEN1).Average age at presentation: 49 years.Carcinoids show a strong male predominance .

##### Key Radiological Features {#FPar77}

Typically a lobulated, heterogeneous mass in the anterior mediastinum

##### Cytological Features {#FPar78}

Same as pulmonary neuroendocrine tumors; please refer that section in this chapter.Representative images are shown in Fig. [6.36](#Fig36){ref-type="fig"}a--i.Fig. 6.36Thymic neuroendocrine tumors. (**a**, **b**) Typical carcinoid, showing loosely cohesive and single of uniform cells with powdery chromatin pattern and discernible nucleoli, Pap stain; (**c**) atypical carcinoid, cellblock material, showing tumor cells forming rosette-like structure, H&E; (**d**) atypical carcinoid, tissue section showing nests of tumor cells, H&E; (**e**) atypical carcinoid, diffuse staining for chromogranin, IHC; (**f**, **g**) high-grade neuroendocrine carcinoma showing discohesive cells with moderate nuclear pleomorphism, prominent nucleoli and frequent mitoses, most compatible with large cell type, Diff-Quik (**f**) and Pap (**g**) stains; (**h**, **i**) high-grade neuroendocrine carcinoma showing discohesive small cells with nuclear molding, inconspicuous nucleoli and frequent mitoses, most compatible with small cell type, Diff-Quik (**h**) and Pap (**i**) stains

##### Differential Diagnosis {#FPar79}

Pulmonary neuroendocrine tumors: careful clinical and radiological correlation is the primary way to distinguish pulmonary from thymic neuroendocrine tumors.Thymoma, especially type A, to distinguish from carcinoids.Thymic carcinoma usually shows focal and/or weak expression of neuroendocrine markers.

##### Histology {#FPar80}

The same as pulmonary neuroendocrine tumors, respectively.

**Immunohistochemistry**

Same as the pulmonary neuroendocrine tumors, respectively .

#### Germ Cell Tumors of the Mediastinum {#Sec40}

##### Key Clinical Features {#FPar81}

Accounts for 3--4% of all germ cell tumors; up to 16% of all mediastinal tumorsIn prepubertal patients (mean \<8 years): teratomas (58%), yolk sac tumors +/− teratoma (42%)In postpubertal female patients: teratoma (93%), seminoma (dysgerminoma) (4%), embryonal carcinoma (2%), and others (\<1%)In postpubertal male patients (mean 25--29 years): teratoma (35%), seminoma (32%), mixed (16%), yolk sac tumor (10%), embryonal carcinoma (4%), and choriocarcinoma (3%)In patients with Klinefelter syndrome: mediastinal non-seminomatous germ cell tumors particularly common but not seminomas or testicular germ cell tumorsDepending on tumor type, may have increased serum levels of the β-subunit of human chorionic gonadotropin (βhCG), α-fetoprotein (AFP), and lactate dehydrogenase

##### Key Radiological Features {#FPar82}

Anterior mediastinal mass: uncalcified and homogeneous for seminomas, heterogeneous with central attenuation, and a frond-like periphery for non-seminomatous germ cell tumors.Multilocular cystic lesions can accompany any type of mediastinal germ cell tumor (particularly seminomas), also others, such as thymomas, thymic carcinomas, Hodgkin or non-Hodgkin lymphomas, and metastases .

##### Cytological Features {#FPar83}

Seminomas :Highly cellular smears composed of small loose syncytium-like clusters or isolated large tumor cells with centrally located round nuclei containing one or more prominent, irregular nucleoli, and clear to granular cytoplasm.Mitoses present.Admixed with polymorphous lymphocytes, occasional epithelioid histiocytes.A characteristic tigroid background.Representative images are shown in Fig. [6.37](#Fig37){ref-type="fig"}a--h.Fig. 6.37Seminoma , mediastinum. (**a**--**c**) The smears reveal small loose syncytium-like clusters and isolated large tumor cells with centrally located round nuclei containing one or more prominent, irregular nucleoli, and clear to granular cytoplasm, with admixed polymorphous lymphocytes, in a characteristic tigroid background, Diff-Quik; (**d**) cell block preparation reveals thin core of tumor tissue showing small clusters of atypical cells with prominent nucleoli admixed with lymphocytes, H&E; (**e**) positive for SALL4, IHC; (**f**) positive for OCT4, IHC; (**g**) positive for CD117, IHC; (**h**) negative for CD30, IHCEmbryonal carcinomas :Highly cellular smearsThree-dimensional clusters or sheets of large, pleomorphic tumor cells with high nuclear-to-cytoplasmic ratio, irregular nuclear contours, coarse chromatin, and several nucleoliIndistinct pale cytoplasmBizarre-shaped cells, mitoses, and necrosis frequentYolk sac tumors :Clusters of medium to large pleomorphic tumor cells with irregular nuclear contours, vesicular nuclei, prominent nucleoli, and eosinophilic or vacuolated cytoplasm.Some tumor cells contain intracytoplasmic dense hyaline globules.Granular debris and mucoid or metachromatic material in background.No lymphocytes or epithelioid histiocytes .Choriocarcinomas :Cellular smearsMalignant cytotrophoblasts: mononucleated, medium-size cells with vacuolated, basophilic cytoplasm, and eccentric nucleiMalignant syncytiotrophoblasts: very large tumor cells with one or several nuclei, distinct nucleoli, and eosinophilic cytoplasmAtypical mitosesSignificant hemorrhage and necrosis in the backgroundTeratoma :Mature teratoma: cytology diagnosis is difficult; may be paucicellular with few anucleated squamous cells and macrophages in a proteinaceous background; ciliated bronchial cells, smooth muscle, and cartilage are present; a mucoid background with bland-looking signet ring cell-like mucus cells may be seen.Immature teratoma: may be cellular, composed of aggregates or individual small, round, hyperchromatic cells with high nuclear-to-cytoplasmic ratio, and inconspicuous nucleoli; rare rosettes with neuropils, rhabdomyoblasts, immature cartilage, and blastema-like stromal cells may be identified .

##### Differential Diagnosis {#FPar84}

Metastatic gonadal germ cell tumorsMetastatic carcinomasSmall round blue cell tumorsSarcomas

##### Histology {#FPar85}

Seminoma : Sheets, cords, or irregular lobules of monotonous, round to polygonal tumor cells with central nuclei, macronucleoli, and abundant clear to lightly eosinophilic cytoplasm.Delicate fibrous septa, with infiltrates of lymphocytes, may form germinal centers.Granulomatous reaction and fibrosis.Syncytiotrophoblastic cells may be scattered throughout . Embryonal carcinoma : Sheets, tubules, and papillary structures of large polygonal or columnar cells with round to oval, vesicular, hyperchromatic nuclei containing one or multiple nucleoli and a moderate amount of cytoplasm.Numerous mitoses, apoptotic bodies, and coagulated necrosis are common.Scattered single or small clusters of syncytiotrophoblasts in one third of cases . Yolk sac tumor : Various patterns: reticular-microcystic, spindle cell, solid, macrocystic, papillary, forming Schiller-Duval bodies, polyvesicular vitelline, glandular-alveolar, and hepatoid patterns.The tumor cells may be flat or columnar, with intracellular and extracellular hyaline globules, as well as basement membrane-like material deposition between the cells . Choriocarcinoma : Two cell components, syncytiotrophoblasts and cytotrophoblasts, arranged in solid nests or sheets, occasionally in a villus-like arrangement.The syncytiotrophoblasts are large, vacuolated, multinucleated giant cells with dark eosinophilic cytoplasm.The cytotrophoblasts are uniform, medium-size, polygonal cells with abundant clear cytoplasm and distinct cytoplasmic borders.Hemorrhage and necrosis are frequently observed . Teratoma : Mature teratoma: solid or multicystic; cysts may be filled with clear, keratinous, gelatinous, or mucinous material; cartilage, spicules of bone, patches of pigmented tissue, or brain tissue may be discernible; an admixture of ectoderm, endoderm, and mesoderm is seen, assembled in either a disorganized or organized pattern.Immature teratoma: the immature teratomatous elements are mostly cellular spindle mesenchymal components, but immature neural and epithelial elements can be seen; frequent mitoses; embryonic rhabdomyoblastic tissue, blastomatous tissue resembling embryonic kidney or lung, primitive neuroectodermal tumor (PNET), and other epithelial or mesenchymal malignant transformations can be seen .

**Immunohistochemistry**

The immunophenotypes of mediastinal germ cell tumors are summarized in Table [6.14](#Tab14){ref-type="table"}.Table 6.14Immunophenotypic features of mediastinal germ cell tum orsTumors/AntibodyCKOCT3/4SALL4CD117CD30AFPβhCGGly-3Seminoma−/++++−−−^e^−Embryonal CA+++−/++−/+−^e^−/+Yolk Sac Tumor+−++/−−+−+Choriocarcinoma+−+^b^−−−++/−^f^Teratoma+^a^−−/+^c^−/+−−/+^d^−+/−*CK* cytokeratin, *OCT3/4* octamer-binding transcription factor 3/4, *SALL4* Sal-like protein 4, *CD* cluster of differentiation, *AFP* α-fetoprotein, *βhCG* B subunit of human chorionic gonadotropin, *Gly-3* glypican 3, *CA* carcinoma^a^Epithelial component^b^Mononuclear trophoblast^c^Focal staining in enteric glands, primitive neuroepithelium, and blastema-like stroma of immature teratoma^d^AFP can be positive in fetal gut, liver, or neuroepithelium in immature teratoma^e^Positive in scattered syncytiotrophoblasts^f^Positive in syncytiotrophoblasts

#### Lymphomas of the Mediastinum {#Sec41}

##### Primary Mediastinal Large B-Cell Lymphoma {#Sec42}

###### Key Clinical Features {#FPar86}

An aggressive large B-cell lymphoma, of putative thymic B-cell originAccounting for 2--3% of all non-Hodgkin lymphomasPredominantly in young adults, third to fourth decadesFemale predominanceNo known risk factors

###### Key Radiographic Features {#FPar87}

Anterior-superior mediastinal mass, often bulky, invading adjacent structuresThe mass typically shows a regular contour.

###### Cytological Features {#FPar88}

Atypical medial to large-size, monomorphic lymphoid cells with irregular, round to oval nuclei, small nucleoli and clear to eosinophilic cytoplasmBackground of lymphoglandular bodies and abundant necrosis

###### Differential Diagnosis {#FPar89}

Diffuse large B-cell lymphomaHodgkin lymphoma

###### Histology {#FPar90}

Diffuse, sheets, or clusters of medium to large, monomorphic tumor cells with irregular, round to oval nuclei, small nucleoli, and clear or eosinophilic cytoplasm; some cases show cells with pleomorphic nuclei and abundant amphophilic cytoplasm resembling Hodgkin lymphoma or non-lymphoid tumors.Admixed, especially at the periphery, are reactive lymphocytes, macrophages, and granulocytes.Distinct fibrosis to form irregular collagen bands dividing tumor into variable size compartments .

**Immunohistochemistry** Express CD19, CD20, CD22, and CD79a.Express PAX5, B-cell Oct-binding protein 1 (BOB1), OCT2, and PU.1.Lack expression of immunoglobulin; CD10 is often negative.CD30 expression in \>80% of cases, but usually weak and heterogeneous.Positive for interferon regulatory factor 4/multiple myeloma oncogene 1 (IRF4/MUM1) (75%), CD23 (70%), and variable to Bcl2 and Bcl6.Positive for myelin and lymphocyte (MAL) antigen, CD54, CD95, tumor necrosis factor receptor 1 (TRAF1), p63, and nuclear REL .

##### Other Types of Lymphomas {#Sec43}

Refer to Chap. 10.1007/978-3-319-57386-1_4 on lymph nodes.

 {#Sec44}

Case Scenario 1: Reactive Metaplastic Changes in Viral Infection {#Sec45}
----------------------------------------------------------------

### Learning Objectives {#Sec46}

To describe the cytological features of this entityTo become aware of its cytologic atypia, a potential mimic of malignancyTo become familiar with the utility of lab tests in the diagnosis of this entity

### Case {#Sec47}

A 14-year-old female with a medical history of Rett syndrome presented with respiratory illness, fatigue, and pneumonia for 2--3 months. Respiratory secretion for culture and RT-PCR and bronchial washing for cytology and differential cell count were received.

The bronchial washing specimen revealed scattered atypical squamoid cells with large nuclei, high nuclear-to-cytoplasmic ratio, and hyperchromatic, smudged chromatin with a suggestion of nuclear inclusions in background of intense acute inflammation, reactive respiratory epithelial cells, and pulmonary macrophages. The cellblock material showed similar findings. Immunohistochemically, the scattered atypical cells were decorated by CK7, but nonreactive to p40; the profile suggested that those cells are pneumocytes. Representative images are shown in Fig. [6.38](#Fig38){ref-type="fig"}a--d.Fig. 6.38Bronchial washing , in patient with coronavirus infection. (**a**) Atypical pneumocytes with large atypical nuclei, prominent eosinophilic nucleoli, and granular amphophilic cytoplasm, Pap stain; (**b**, **c**) scattered atypical metaplastic squamous cells with smudged chromatin, Pap stain; (**d**) CK7 highlights the atypical pneumocytes, IHC

SARS, a new human emergent infectious disease mainly involving the lower respiratory tract, became a worldwide outbreak in 2003, affecting more than 8000 patients, with a fatality rate of 9.2%. A novel coronavirus (SARS-CoV), a member of a family of large, positive, single-stranded RNA viruses, was identified as the etiological agent for this disease. The key pulmonary pathology is that of DAD, featured by pronounced pulmonary edema and hyaline membrane formation. There are interstitial thickening, fibrosis, and intra-alveolar exudates with granulation tissue formation, as well as sparsely inflammatory cell infiltrates, including macrophages (often multinucleated forms) and lymphocytes. Depending on different phases in the disease progression, the degree of fibrosis and the composition of inflammatory cells may vary. Other pathologic findings, such as prominent vascular injury, hemophagocytosis, squamous metaplasia, apoptosis, and atypical pneumocytes, including multinucleated giant pneumocytes with irregularly distributed nuclei or pneumocytes with large atypical nuclei, prominent eosinophilic nucleoli, and granular amphophilic cytoplasm, were reported. However, distinct viral inclusions were not apparent. Ancillary tests, such as in situ hybridization, immunohistochemistry, viral isolation, or RT-PCR are necessary to confirm the viral infection.

For the index case, serology testing and culture of the respiratory secretion were positive for coronavirus OC43. Electron microscopy (EM) revealed viral-like particles in pneumocytes, but not in macrophages or other cell types of lung. The findings confirmed the viral infection.

The atypical pneumocytes, metaplastic squamous cells, and apoptosis may mimic malignancy. Caution should be exercised in the interpretation of specimens from patients with a history of SARS and coronavirus infection. The awareness of clinical history and the limited amount of atypical cells should alert the pathologists to avoid overdiagnosis in this clinical setting.

Case Scenario 2: Metastatic Melanoma {#Sec48}
------------------------------------

### Learning Objectives {#Sec49}

To describe the cytological features of this entityTo become aware of the common differential diagnoses of this tumorTo become familiar with the potential utility of the immunohistochemical markers in the diagnosis of this tumor

### Case {#Sec50}

An 81-year-old gentleman with no documented past history of malignancy presented with dizziness and difficulty of breathing. CT imaging of the chest revealed multiple lung nodules and lymphadenopathy. In addition, a possible brain lesion was noted on imaging. An ultrasound-guided FNA of the hilar lymph node was performed. The smears were highly cellular, composed of clusters, aggregated cell groups, and abundant single spindled to plump cells with hyperchromatic nuclei without prominent nucleoli. Some rosette-like structures were seen, as well as scattered pigment-laden macrophages. The pigments were dusky and brown granules on Pap stain and blue-black on Diff-Quik stain. Abundant necrosis was noted. Representative images of the FNA smears and cellblock material were shown in Fig. [6.39](#Fig39){ref-type="fig"}a--d.Fig. 6.39Metastatic spindle cell melanoma . (**a**) Highly cellular smears, comprised of clusters and abundant singly spindle to plump cells with hyperchromatic nuclei without discernible nucleoli, Diff-Quik; (**b**) some rosette-like structures are seen, as well as scattered pigment laden macrophages; the pigments are dusky, blue-black, Diff-Quik; (**c**, **d**) same as **b**, the pigments are brown, granular, Pap stain; (**e**) cellblock preparation reveals spindled cells with perivascular palisading; scattered pigment-laden macrophages are seen, but not shown, H&E; (**f**) diffuse positive for HMB-45, IHC; (**g**) strong, diffuse SOX10 nuclear staining, IHC; (**h**) no CK AE1/3 expression, IHC

The cytological features raise a differential diagnosis that includes neuroendocrine tumor, spindle cell tumors, including sarcomatoid carcinoma and metastatic melanoma of the spindle cell type. A limited panel of immunoassays was performed, revealing tumor cells with strong and diffuse nuclear staining for sex determining region Y box 10 ( SOX10) and cytoplasmic staining for vimentin and human melanoma black 45 ( HMB45), focally for melanoma antigen recognized by T cells ( MART1) and S100 (both nuclear and cytoplasmic), while CK AE1/3 and neuroendocrine markers ( synaptophysin, chromogranin and CD56) were nonreactive. Representative images are illustrated in Fig. [6.39](#Fig39){ref-type="fig"}e--h. The overall findings are those of a metastatic spindle cell melanoma.

The diagnosis of metastatic spindle cell melanoma can be challenging on FNA specimens. The spindled tumor cells can display a wide range of morphologies, from deceptively bland-appearing reactive fibroblast-like cells to highly pleomorphic, high-grade sarcomatous spindle cells. The diagnostic cytological features of conventional melanoma, such as a dispersed single cell pattern, eccentric nuclei, cytoplasmic melanin pigments, intranuclear pseudoinclusions, prominent macronucleoli, and bi- or multinucleations, are often subtle or even lacking. For the index case, the presence of melanin pigments is a valuable clue to raise the suspicion for melanoma which, in conjunction with the immunophenotype, justified the diagnosis of spindle cell melanoma. The presence of cytoplasmic melanin pigments in FNA samples varies, reported in the range of 30--80%. However, these pigments can occasionally be identified in melanotic schwannomas and melanotic malignant peripheral nerve sheath tumors ( MPNSTs).

Immunohistochemistry plays a critical role in the diagnosis of spindle cell melanoma, especially in the clinical scenario of metastasis. Metastatic spindle cell melanomas tend to lose expression of some melanoma markers. Piao and colleagues reported that spindle cell melanomas express S100, HMB45, and MART1 in 67%, 50%, and 18% of cases, respectively. Although the sensitivity of S100 for melanoma in general is very high (\~93--100%), its specificity is low. The expression of S100 can be seen in a variety of tumors. HMB45 is expressed in melanocytic tumors, also in clear cell sarcomas, perivascular epithelial cell tumors (PEComas), melanocytic schwannomas, meningeal melanocytomas, some ovarian steroid tumors, and renal cell carcinomas with the t(6;11)(p29;q12) translocation. The sensitivity of HMB45 for melanoma in general is in the range of 70--90%, but only 0--30% for desmoplastic melanomas. MART1 has a sensitivity of \~85--97% for primary and \~57--92% for metastatic melanomas, but only 0--33% for desmoplastic melanomas; its specificity for melanoma is 95--100%. MART1 expression is also seen in PEComas and clear cell sarcomas.

SOX10 is a transcription factor that is essential for the survival of neural crest-derived cells and for the maintenance of the multipotency of neural crest cells. The cells derived from neural crest multipotential cells include neurons and glial cells in the peripheral nervous system, melanocytes of the skin, C cells of the thyroid, catecholaminergic cells of the adrenal gland, and cartilage and bone of the face. Studies have shown that, among tumors, SOX10 is commonly expressed in melanomas, including desmoplastic melanomas, tumors with Schwann cell differentiation, myoepithelial cell tumors of the soft tissue and some salivary gland neoplasms, particularly those with myoepithelial differentiation, and acinic cell carcinomas. When compared with other melanocytic-associated markers, SOX10 is highly sensitive and specific and can assist in the differential diagnosis of melanomas. Even in desmoplastic melanomas, SOX10 expression was reported in 100% of cases. Studies of SOX10 expression in tumors of the nervous system reported that SOX10 is commonly expressed in schwannomas (100%), neurofibromas (98--100%), and, less frequently, MPNSTs (\~50--55%).

The differential diagnosis of this case is summarized in Table [6.15](#Tab15){ref-type="table"}.Table 6.15Immnohistochemical differential diagnosis of spindle cell melanomaMSMNETSCMPNSTSOX10+−−−/+S100+−−−/+CK AE1/3−++−SYN−+−−CHR−+−−HMB45−/+−−−MART1−/+−−−*MSM* malignant spindle cell melanoma, *NET* neuroendocrine tumor, *SC* sarcomatoid carcinoma, *MPNST* malignant peripheral nerve sheath tumor, *SOX10* sex determining region Y box 10, *CK* cytokeratin, *SYN* synaptophysin, *CHR* chromogranin, *HMB45* human melanoma black 45, *MART1* melanoma antigen recognized by T cells

Case Scenario 3: Metastatic Carcinoma {#Sec51}
-------------------------------------

### Learning Objectives {#Sec52}

To describe the cytological features of this entityTo become aware of the subtle differences in cytology and to raise the question of a metastasisTo become familiar with the potential utility of immunohistochemical markers in the diagnosis of this tumor

### Case {#Sec53}

A 72-year-old female with a past medical history of noninvasive low-grade papillary urothelial carcinoma a year ago presented with coughing and chest pain for month. CT imaging of the chest revealed multiple lung nodules and lymphadenopathy. An ultrasound-guided FNA and biopsy of the hilar lymph node were performed. The smears were highly cellular, composed of loosely cohesive clusters and single spindle to plump cells with hyperchromatic nuclei, coarse chromatin, occasional discernible to prominent nucleoli, and abundant delicate cytoplasm without defined borders. Some of the cells appeared spindled, columnar or racket-shaped, with eccentrically located nuclei and cytoplasmic tails, also called cercariform cells. Abundant necrosis was noted in the background. Representative images of the FNA smears and biopsy are shown in Fig. [6.40](#Fig40){ref-type="fig"}a--f.Fig. 6.40Metastatic urothelial carcinoma , hilar lymph node, fine needle aspiration with biopsy. (**a**) Loosely cohesive atypical cells with pleomorphic and hyperchromatic nuclei, Diff-Quik; (**b**) the tumor cells show eccentrically placed, oval-shaped nuclei, and abundant cytoplasm, Diff-Quik; (**c**) multilayered papillary fragments, Pap stain; (**d**) many racket-shaped cells, also called cercariform cells showing eccentrically located nuclei with cytoplasmic tails, Pap stain; (**e**) biopsy, H&E; (**f**) positive for CK7, IHC; (**g**) positive for CK20, IHC; (**h**) positive for GATA3, IHC; (**i**) positive for uroplakin II, IHC; (**j**) positive for S100P, IHC

The cytological features raise a differential diagnosis that includes a non- small cell carcinoma of lung, especially squamous cell carcinoma, a sarcomatoid carcinoma, and metastatic carcinoma, especially metastatic urothelial carcinoma. A panel of immunoassays was performed, revealing that the tumor cells were positive for CK7, CK20 (focal), CK5/6, uroplakin II, p40, and placental S100 (S100P) while negative for TTF1, napsin A, synaptophysin, and chromogranin. Representative images are illustrated in Fig. [6.40](#Fig40){ref-type="fig"}g--j. The final diagnosis is metastatic carcinoma with urothelial differentiation

There are limited reports in literature regarding the cytology of metastatic urothelial carcinomas. The following features were reported: (1) loosely cohesive cells occurring singly and in syncytial clusters; (2) large hyperchromatic nuclei with irregularly distributed granular chromatin and abundant granular or fibrillar cytoplasm; (3) distinct cell borders; (4) multilayered papillary fragments; (5) cells with eccentric nuclei, multiple nucleoli, and intracytoplasmic vacuoles; and (6) cercariform cells, "bipolar" cells, and spindled-shaped cells. Among those, multilayered papillary fragments and cercariform cells are the most helpful features in the distinction of urothelial carcinoma from others. The cercariform cells, first described in 1993 by Johnson and Kini and further defined in 1995 by Powers and Elbadawi, are fusiform, pyramidal, or racket-like cells with eccentric nuclei that form non-tapering, flattened, bulbous, or fishtail-like cytoplasmic extensions in varying lengths. The presence of a small vacuole in the bulbous tail was also a helpful criterion. These cells, which are encountered in 57--100% of metastatic urothelial carcinomas, are interpreted in favor of urothelial carcinoma, particularly when they are observed in large numbers. However, they are not specific and must be considered alongside other clinical and morphological characteristics and immunohistochemical phenotypes. The cytological features of metastatic urothelial carcinomas are very difficult to differentiate from mesenchymal tumors and squamous cell carcinomas. Immunohistochemical analyses play a crucial role.

Urothelial cell carcinomas express both CK7 and CK20. In addition, they express HMWCKs ( CK5/6, CK903), p63, GATA binding protein 3 ( GATA3), uroplakin II, and S100P. GATA3 is a zinc finger transcription factor with a diverse range of biologic roles. GATA3 is a newer generation of urothelial specific marker. GATA3 expression was reported in approximately 80% of urothelial carcinomas, over 90% of breast carcinomas, 100% of parathyroid gland tissue or tumors, salivary gland tumors, especially the salivary ductal carcinomas (\~90%), and transitional proliferations of the gynecological tract. In addition, 0--12% of pulmonary squamous cell carcinomas and approximately 10% of pancreatic carcinomas were also reported to be positive for GATA3, although weakly and focally in the majority of positive cases.

The immunohistochemical differential diagnosis of metastatic urothelial carcinomas is summarized in Table [6.16](#Tab16){ref-type="table"}.Table 6.16Immunohistochemical differential diagnosis of metastatic urothelial carcinomaMet UCASqCCSarcomatoid CACK7+−−/+CK20+/−−−CK5/6+++/−TTF1−−−/+GATA3+−/+^a^−Uroplakin II+−−p63+/−+−/+S100P+−−*Met UCA* metastatic urothelial carcinoma, *SqCC* squamous cell carcinoma, *CA* carcinoma, *CK* cytokeratin, *TTF1* thyroid transcription factor 1, *GATA3* GATA binding protein 3, *S100P* placental S100^a^ GATA3 expression in squamous cell carcinoma of lung was reported in 0--12% of cases; when positive, it is usually weak and focal.

Abbreviations List {#Sec54}
==================

AbbreviationFull TextADCAdenocarcinomaAFPAlpha-fetoprotein (α-fetoprotein)AIDSAcquired immunodeficiency syndromeAISAdenocarcinoma in situAKTProtein kinase BALCLAnaplastic large cell lymphomaALKAnaplastic lymphoma kinaseATSAmerican Thoracic SocietyB72.3Tumor-associated glycoprotein (TAG)72BACBronchioloalveolar carcinomaBAP1BRCA1 associated protein 1Bcl (Bcl2, Bcl6)B-cell CLL/lymphoma 2, 6BerEP4Epithelial cell adhesion moleculeBOB1B-cell Oct-binding protein 1BRDBromodomain containing (BRD3, BRD4)CACarcinomaCCNE1Cyclin E1CDCluster of differentiationCDKN2Cyclin-dependent kinase inhibitor 2 (CDKN2A, CDKN2B)CEACarcinoembryonic antigenCHRChromogranin (table only)CKCytokeratinCREB1CAMP responsive element binding proteinCTComputed tomographyCTNNB1Catenin beta 1CUL3Cullen 3DADDiffuse alveolar damageEBVEpstein-Barr virusEGFREpithelial growth factor receptorEMElectron microscopyEMAEpithelial membrane antigenEML4Echinoderm microtubule-associated protein-like 4ERSEuropean Respiratory SocietyEWSR1Ewing sarcoma break point region 1FFocal (table)FDGfluorodeoxyglucoseFGFR1Fibroblast growth factor receptor 1FNAFine needle aspirationFOXN1Forkhead box N1GATA3GATA binding protein 3GIGastrointestinalGLUT1Glucose transporter 1Gly3Glypican 3GMSGrocott's methenamine silverGTF2IGeneral transcription factor IIiGYNGynecologicH&EHematoxylin and eosinHMB45Human melanoma black 45HMGA2High-mobility group AT-hook 2HMWCKHigh molecular weight cytokeratinIASCLInternational Association for the Study of Lung CancerIgImmunoglobulinIHCImmunohistochemistry (only in table)IMP3Insulin-like growth factor II messenger RNA proteinIRF4Interferon regulatory factor 4KEAP1Kelch-like ECH-associated protein 1KITKRASKirsten rat sarcoma viral oncogeneLCNECLarge cell neuroendocrine carcinomaLCNEMLarge cell carcinoma with neuroendocrine morphology (in table only)LeuM1Cluster of differentiation (CD)15LGLow grade (table only)LMWCKLow molecular weight cytokeratinLPPLipoma preferred partnerMALMyelin and lymphocyteMALTMucosa-associated lymphoid tissueMART1Melanoma antigen recognized by T cellsMDM2Mouse double minute 2 homologMedMedian (table)MEN1Multiple endocrine neoplasia type 1Met UCAMetastatic urothelial carcinomaMIAMinimally invasive adenocarcinomaMIB1Mindbomb E3 ubiquitin protein ligase 1MPNSTMalignant peripheral nerve sheath tumorMRIMagnetic resonance imagingMSAMuscle-specific actinMSMMalignant spindle cell melanomaMUCMucin (e.g., MUC1)MUM1Multiple myeloma oncogene 1N/CNuclear-to-cytoplasmic ratioNATB2NGFI-A binding protein 2NENeuroendocrineNETNeuroendocrine tumorNF2Neurofibromin 2NFE2L2Nuclear factor, erythroid 2 like 2NKNatural killerNKX3.1NK3 homeobox 1NOSNot otherwise specifiedNOTCH1Notch (Drosophila) homolog 1NSCCNon-small cell carcinoma (in tables only)NSCLCNon-small cell lung carcinomaNUTNuclear protein in testisOCT3/4Octamer-binding transcription factor 3/4OT2PapPapanicolaouPASPeriodic acid-SchiffPAXPaired box gene (PAX5, PAX8)PEComaPerivascular epithelioid cell tumorPEComatousPerivascular epithelioid cell (PEC)omatous tumorsPETPositron emission tomographyPNETPrimitive neuroectodermal tumorPU.1RB1Retinoblastoma 1RELRNARibonucleic acidRT-PCRReverse transcription polymerase chain reactionS100PPlacental S100SALL4Sal-like protein 4SARSSevere acute respiratory syndromeSARS-CoVSevere acute respiratory syndrome caused by coronavirus (SARS coronavirus)SATB2Special AT-rich sequence-binding protein 2SCSarcomatoidSCNCSmall cell neuroendocrine carcinomaSMASmooth muscle actinSOXSex-determining region Y box (SOX1, SOX10, etc.)spp.Species (many)SqCCSquamous cell carcinoma (in tables only)STAT6Signal transducer and activator of transcription 6SYNSynaptophysinTdTTerminal deoxynucleotidyl transferaseTPTumor protein (TP53, TP63)TRAFTumor necrosis factor receptorTTF1Thyroid transcription factor 1WHOWorld Health OrganizationWT1Wilms tumor 1βhCGB subunit of human chorionic gonadotropin
